| Year |
Citation |
Score |
| 2024 |
Gladman DD, Chandran V, Rosen CF, Rohekar S, Boyd T, Eder L, Rahman P, Dutz J, Chan J, Haydey RP, Barac S, Laliberté MC, Girard T, Fournier PA, Sutton M, et al. Residual Disease Activity In Canadian Patients With Psoriatic Arthritis (PsA) Treated With Advanced Therapies: Results From A Multi-Registry Analysis (UNISON-PsA). The Journal of Rheumatology. PMID 38359937 DOI: 10.3899/jrheum.2023-0716 |
0.666 |
|
| 2023 |
Chandran V, Malkov VA, Ito KL, Liu Y, Vestergaard L, Yoon OK, Liu J, Trivedi M, Hertz A, Gladman D. Pharmacodynamic effects of filgotinib treatment driving clinical improvement in patients with active psoriatic arthritis enrolled in the EQUATOR trial. Rmd Open. 9. PMID 37945284 DOI: 10.1136/rmdopen-2023-003550 |
0.498 |
|
| 2023 |
Dand N, Stuart PE, Bowes J, Ellinghaus D, Nititham J, Saklatvala JR, Teder-Laving M, Thomas LF, Traks T, Uebe S, Assmann G, Baudry D, Behrens F, Billi AC, Brown MA, ... ... Gladman DD, et al. GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets. Medrxiv : the Preprint Server For Health Sciences. PMID 37873414 DOI: 10.1101/2023.10.04.23296543 |
0.438 |
|
| 2023 |
Colaco K, Lee KA, Akhtari S, Winer R, Chandran V, Harvey P, Cook RJ, Piguet V, Gladman DD, Eder L. Derivation and Internal Validation of a Disease-specific Cardiovascular Risk Prediction Model for Patients with Psoriatic Arthritis and Psoriasis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 37691498 DOI: 10.1002/art.42694 |
0.636 |
|
| 2023 |
Pirouzmand N, Pereira D, Sutton M, Mathew AJ, Chandran V, Gladman DD. Psoriatic Arthritis And Covid-19 - Patient Perspectives In A Large Psoriatic Arthritis Cohort. The Journal of Rheumatology. PMID 37657794 DOI: 10.3899/jrheum.2022-1265 |
0.498 |
|
| 2023 |
Eder L, Lee KA, Chandran V, Widdifield J, Drucker AM, Ritchlin C, Rosen CF, Cook RJ, Gladman DD. Derivation of a multivariable psoriatic arthritis risk estimation tool (PRESTO): a step towards prevention. Arthritis & Rheumatology (Hoboken, N.J.). PMID 37555242 DOI: 10.1002/art.42661 |
0.642 |
|
| 2023 |
Ng BCK, Jadon D, Behrens F, de Wit M, FitzGerald O, Gladman DD, Mease PJ, O'Sullivan D, Pennington SR, Schett G, Chandran V, de Vlam K. Proceedings of the Collaborative Research Network Meeting at the GRAPPA 2022 Annual Meeting. The Journal of Rheumatology. PMID 37527862 DOI: 10.3899/jrheum.2023-0534 |
0.437 |
|
| 2023 |
Ng BCK, Jadon D, Adebajo A, Ayan G, Callis Duffin K, Chandran V, Coates LC, D'Agostino MA, de Vlam K, Deodhar A, Eder L, Garg A, Gladman DD, Goel N, Gottlieb AB, et al. Proceedings of the GRAPPA 2022 Executive Retreat. The Journal of Rheumatology. PMID 37527861 DOI: 10.3899/jrheum.2023-0537 |
0.601 |
|
| 2023 |
Eder L, Gladman DD, Mease P, Pollock RA, Luna R, Aydin SZ, Ogdie A, Polachek A, Gruben D, Cadatal MJ, Kinch C, Strand V. Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension. Rmd Open. 9. PMID 36958766 DOI: 10.1136/rmdopen-2022-002718 |
0.509 |
|
| 2023 |
Rida MA, Lee KA, Chandran V, Cook RJ, Gladman DD. Persistence of Biologics in the Treatment of Psoriatic Arthritis (Psa): Data From a Large Hospital Based Longitudinal Cohort. Arthritis Care & Research. PMID 36913183 DOI: 10.1002/acr.25112 |
0.431 |
|
| 2022 |
Kwok TSH, Sutton M, Cook RJ, Pereira D, Chandran V, Gladman DD. Musculoskeletal Surgery in Psoriatic Arthritis: Prevalence and Risk Factors. The Journal of Rheumatology. PMID 36379576 DOI: 10.3899/jrheum.220908 |
0.416 |
|
| 2022 |
Coates LC, Soriano ER, Corp N, Bertheussen H, Callis Duffin K, Campanholo CB, Chau J, Eder L, Fernández-Ávila DG, FitzGerald O, Garg A, Gladman DD, Goel N, Helliwell PS, Husni ME, et al. Author Correction: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nature Reviews. Rheumatology. PMID 36216924 DOI: 10.1038/s41584-022-00861-w |
0.525 |
|
| 2022 |
Kwok TSH, Sutton M, Pereira D, Cook RJ, Chandran V, Haroon N, Inman RD, Gladman DD. Isolated axial disease in psoriatic arthritis and ankylosing spondylitis with psoriasis. Annals of the Rheumatic Diseases. PMID 35973805 DOI: 10.1136/ard-2022-222537 |
0.476 |
|
| 2022 |
Park S, Silverberg OM, Moez E, Chandran V, Gladman DD. Investigation into the wait time for consultation in the psoriatic arthritis program. Clinical Rheumatology. PMID 35869318 DOI: 10.1007/s10067-022-06288-8 |
0.519 |
|
| 2022 |
Helliwell PS, Mease PJ, Kavanaugh A, Coates LC, Ogdie A, Deodhar A, Strand V, Kricorian G, Liu LXH, Collier D, Gladman DD. Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial. Rmd Open. 8. PMID 35863864 DOI: 10.1136/rmdopen-2022-002366 |
0.306 |
|
| 2022 |
Coates LC, Soriano ER, Corp N, Bertheussen H, Callis Duffin K, Campanholo CB, Chau J, Eder L, Fernández-Ávila DG, FitzGerald O, Garg A, Gladman DD, Goel N, Helliwell PS, Husni ME, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nature Reviews. Rheumatology. PMID 35761070 DOI: 10.1038/s41584-022-00798-0 |
0.549 |
|
| 2022 |
Mathew AJ, Sutton M, Pereira D, Gladman DD, Chandran V. Effectiveness of Disease Modifying Anti-Rheumatic Drugs for Enthesitis in a Prospective Longitudinal Psoriatic Arthritis Cohort. The Journal of Rheumatology. PMID 35649547 DOI: 10.3899/jrheum.211231 |
0.452 |
|
| 2022 |
Mease P, Kavanaugh A, Gladman D, FitzGerald O, Soriano ER, Nash P, Feng D, Lertratanakul A, Douglas K, Lippe R, Gossec L. Disease Control with Upadacitinib in Patients with Psoriatic Arthritis: A Post Hoc Analysis of the Randomized, Placebo-Controlled SELECT-PsA 1 and 2 Phase 3 Trials. Rheumatology and Therapy. PMID 35606663 DOI: 10.1007/s40744-022-00449-6 |
0.329 |
|
| 2022 |
Colaço K, Lee KA, Akhtari S, Winer R, Welsh P, Sattar N, McInnes IB, Chandran V, Harvey P, Cook RJ, Gladman DD, Piguet V, Eder L. Association of Cardiac Biomarkers with Cardiovascular Outcomes in Patients with Psoriatic Arthritis and Psoriasis: A Longitudinal Cohort Study. Arthritis & Rheumatology (Hoboken, N.J.). PMID 35261189 DOI: 10.1002/art.42079 |
0.639 |
|
| 2022 |
Damian AC, Colaco K, Rohekar S, Boyd T, Chandran V, Gladman DD, Cook R, Eder L. The incidence and risk factors for venous thromboembolic events in patients with psoriasis and psoriatic arthritis. Seminars in Arthritis and Rheumatism. 53: 151950. PMID 35078035 DOI: 10.1016/j.semarthrit.2022.151950 |
0.638 |
|
| 2021 |
Poddubnyy D, Baraliakos X, Van den Bosch F, Braun J, Coates LC, Chandran V, Diekhoff T, van Gaalen FA, Gensler LS, Goel N, Gottlieb AB, van der Heijde D, Helliwell PS, Hermann KGA, Jadon D, ... ... Gladman DD, et al. Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Therapeutic Advances in Musculoskeletal Disease. 13: 1759720X211057975. PMID 34987619 DOI: 10.1177/1759720X211057975 |
0.567 |
|
| 2021 |
Taylor JH, Deo M, Sutton M, Chandran V, Shanmugarajah S, Pereira D, Gladman DD, Rosen CF. Assessment of the Toronto Psoriatic Arthritis Screen 2 as a Screening Tool for Psoriasis. Journal of Cutaneous Medicine and Surgery. 12034754211061085. PMID 34841919 DOI: 10.1177/12034754211061085 |
0.439 |
|
| 2021 |
Strand V, Mease PJ, Soriano ER, Kishimoto M, Salvarani C, Saffore CD, Zueger P, McDearmon-Blondell E, Kato K, Gladman DD. Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1. Rheumatology and Therapy. PMID 34636026 DOI: 10.1007/s40744-021-00379-9 |
0.322 |
|
| 2021 |
Hanna N, Silverberg OM, Reaume M, Gladman D, Davis MDP, Piguet V, Alavi A. Incidence, prevalence, and predictors of inflammatory arthritis in patients with hidradenitis suppurativa: a systematic review and meta-analysis. International Journal of Dermatology. PMID 34432308 DOI: 10.1111/ijd.15860 |
0.341 |
|
| 2021 |
Gladman DD, Ye JY, Chandran V, Lee KA, Cook RJ. Oligoarticular Versus Polyarticular Psoriatic Arthritis: A Longitudinal Study Showing Similar Characteristics. The Journal of Rheumatology. PMID 34334360 DOI: 10.3899/jrheum.210434 |
0.522 |
|
| 2021 |
Leung YY, Orbai AM, Tillett W, Ogdie A, Eder L, Goel N, Hojgaard P, Holland R, Mathew AJ, Lindsay CA, Antony A, Chau J, Christensen R, Coates LC, Mease PJ, ... ... Gladman DD, et al. Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group. The Journal of Rheumatology. Supplement. 97: 60-63. PMID 34074670 DOI: 10.3899/jrheum.201679 |
0.49 |
|
| 2021 |
Colaco K, Lee KA, Akhtari S, Winer R, Welsh P, Sattar N, McInnes IB, Chandran V, Harvey P, Cook RJ, Gladman DD, Piguet V, Eder L. Targeted metabolomic profiling and prediction of cardiovascular events: a prospective study of patients with psoriatic arthritis and psoriasis. Annals of the Rheumatic Diseases. PMID 34049856 DOI: 10.1136/annrheumdis-2021-220168 |
0.637 |
|
| 2021 |
Damian AC, Colaco K, Rohekar S, Boyd T, Chandran V, Gladman DD, Cook R, Eder L. The incidence and risk factors for venous thromboembolic events in patients with psoriasis and psoriatic arthritis. Seminars in Arthritis and Rheumatism. 51: 547-552. PMID 33895651 DOI: 10.1016/j.semarthrit.2021.04.008 |
0.634 |
|
| 2021 |
Feld J, Ye JY, Chandran V, Inman RD, Haroon N, Cook R, Gladman DD. Axial Disease in Psoriatic arthritis: The presence and progression of unilateral grade 2 sacroiliitis in a psoriatic arthritis cohort. Seminars in Arthritis and Rheumatism. 51: 464-468. PMID 33774593 DOI: 10.1016/j.semarthrit.2021.03.007 |
0.526 |
|
| 2021 |
Coates LC, Bushmakin AG, FitzGerald O, Gladman DD, Fallon L, Cappelleri JC, Hsu MA, Helliwell PS. Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in phase 3 studies of tofacitinib. Arthritis Research & Therapy. 23: 94. PMID 33766074 DOI: 10.1186/s13075-021-02474-2 |
0.307 |
|
| 2021 |
Wong A, Ye JY, Cook RJ, Gladman DD, Chandran V. Depression and Anxiety Reduce the Probability of Achieving a State of Sustained Minimal Disease Activity in Patients with Psoriatic Arthritis. Arthritis Care & Research. PMID 33662181 DOI: 10.1002/acr.24593 |
0.473 |
|
| 2021 |
Leung YY, Orbai AM, Tillett W, Ogdie A, Eder L, Goel N, Hojgaard P, Holland R, Mathew AJ, Lindsay CA, Antony A, Chau J, Christensen R, Coates LC, Mease PJ, ... ... Gladman DD, et al. Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group. The Journal of Rheumatology. PMID 33649070 DOI: 10.3899/jrheum.201679 |
0.49 |
|
| 2021 |
Koppikar S, Colaco K, Harvey P, Akhtari S, Chandran V, Gladman DD, Cook R, Eder L. Incidence of and Risk Factors for Heart Failure in Patients with Psoriatic Disease - A Cohort Study. Arthritis Care & Research. PMID 33571391 DOI: 10.1002/acr.24578 |
0.61 |
|
| 2020 |
Polachek A, Muntyanu A, Lee KA, Ye JY, Chandran V, Cook RJ, Gladman DD. Malignancy in psoriatic disease: Results from prospective longitudinal cohorts. Seminars in Arthritis and Rheumatism. 51: 144-149. PMID 33383290 DOI: 10.1016/j.semarthrit.2020.12.008 |
0.515 |
|
| 2020 |
Kwok TSH, Sutton M, Yang Ye J, Pereira D, Chandran V, Gladman DD. Prevalence and factors associated with osteoporosis and bone mineral density testing in psoriatic arthritis. Arthritis Care & Research. PMID 33326187 DOI: 10.1002/acr.24538 |
0.423 |
|
| 2020 |
Rahmati S, O'Rielly DD, Li Q, Codner D, Dohey A, Jenkins K, Jurisica I, Gladman DD, Chandran V, Rahman P. Rho-GTPase pathways may differentiate treatment response to TNF-alpha and IL-17A inhibitors in psoriatic arthritis. Scientific Reports. 10: 21703. PMID 33303908 DOI: 10.1038/s41598-020-78866-2 |
0.441 |
|
| 2020 |
Colaco K, Widdifield J, Luo J, Rosen CF, Alhusayen R, Paterson JM, Campbell W, Tu K, Bernatsky S, Gladman DD, Eder L. Trends in Mortality and Cause-specific Mortality among patients with Psoriasis and Psoriatic Arthritis in Ontario, Canada. Journal of the American Academy of Dermatology. PMID 33096129 DOI: 10.1016/j.jaad.2020.10.031 |
0.502 |
|
| 2020 |
Urowitz MB, Gladman DD, Farewell V, Su J, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke AE, Bernatsky S, Gordon C, Hanly JG, Wallace DJ, Isenberg D, Rahman A, et al. Accrual of atherosclerotic vascular events in a multicentre inception SLE cohort. Arthritis & Rheumatology (Hoboken, N.J.). PMID 32515554 DOI: 10.1002/Art.41392 |
0.358 |
|
| 2020 |
Goel N, Coates LC, De Marco G, Eder L, FitzGerald O, Helliwell PS, Leung YY, Maksymowych WP, Mease PJ, Østergaard M, O'Sullivan D, Poddubnyy D, Ritchlin CT, Gladman DD. GRAPPA 2019 Project Report. The Journal of Rheumatology. Supplement. 96: 53-57. PMID 32482770 DOI: 10.3899/Jrheum.200129 |
0.504 |
|
| 2020 |
Leung YY, Tillett W, Orbai AM, Ogdie A, Eder L, Coates LC, Holland R, Antony A, Goel N, Mease PJ, Strand V, FitzGerald O, de Wit M, Lindsay CA, Callis Duffin K, ... Gladman DD, et al. The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates. The Journal of Rheumatology. Supplement. 96: 46-49. PMID 32482768 DOI: 10.3899/Jrheum.200127 |
0.497 |
|
| 2020 |
Elalouf O, Muntyanu A, Polachek A, Pereira D, Ye JY, Lee KA, Chandran V, Cook RJ, Gladman DD. Mortality in psoriatic arthritis: Risk, causes of death, predictors for death. Seminars in Arthritis and Rheumatism. 50: 571-575. PMID 32454305 DOI: 10.1016/J.Semarthrit.2020.04.001 |
0.416 |
|
| 2020 |
Li Q, Chandran V, Tsoi L, O'Rielly D, Nair RP, Gladman D, Elder JT, Rahman P. Quantifying Differences in Heritability among Psoriatic Arthritis (PsA), Cutaneous Psoriasis (PsC) and Psoriasis vulgaris (PsV). Scientific Reports. 10: 4925. PMID 32188927 DOI: 10.1038/S41598-020-61981-5 |
0.58 |
|
| 2020 |
Alharbi S, Ye JY, Lee KA, Chandran V, Cook RJ, Gladman DD. Remission in psoriatic arthritis: Definition and predictors. Seminars in Arthritis and Rheumatism. PMID 32145969 DOI: 10.1016/J.Semarthrit.2020.01.012 |
0.51 |
|
| 2020 |
Coates LC, Baraliakos X, Blanco FJ, Blanco-Morales E, Braun J, Chandran V, Luiz Fernandez-Sueiro J, FitzGerald O, Gallagher P, Gladman DD, Gubar E, Korotaeva T, Loginova E, Lubrano E, Mulero J, et al. The phenotype of axial spondyloarthritis: is it dependent on HLA-B27 status? Arthritis Care & Research. PMID 32100954 DOI: 10.1002/Acr.24174 |
0.373 |
|
| 2020 |
Eder L, Widdifield J, Rosen CF, Alhusayen R, Cheng SY, Young J, Campbell W, Bernatsky S, Gladman DD, Paterson M, Tu K. Identifying and characterizing psoriasis and psoriatic arthritis patients in Ontario administrative data: a population-based study from 1991 to 2015. The Journal of Rheumatology. PMID 32062600 DOI: 10.3899/Jrheum.190659 |
0.547 |
|
| 2020 |
Eder L, Tu K, Rosen CF, Alhusayen R, Cheng SY, Young J, Campbell W, Bernatsky S, Gladman DD, Paterson JM, Widdifield J. Health Care Utilization for Musculoskeletal Issues During the Pre-diagnosis Period in Psoriatic Arthritis - A Population-Based Study. Arthritis Care & Research. PMID 31961491 DOI: 10.1002/Acr.24146 |
0.481 |
|
| 2020 |
Gladman D, Nash P, Goto H, Birt JA, Lin CY, Orbai AM, Kvien TK. Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis. Rmd Open. 6. PMID 31958274 DOI: 10.1136/Rmdopen-2019-000928 |
0.307 |
|
| 2019 |
Pakchotanon R, Ye Y, Cook RJ, Chandran V, Gladman DD. Liver Abnormalities in Patients with Psoriatic Arthritis. The Journal of Rheumatology. PMID 31615918 DOI: 10.3899/Jrheum.181312 |
0.479 |
|
| 2019 |
Feld J, Ye JY, Chandran V, Inman RD, Haroon N, Cook R, Gladman DD. Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis? Rheumatology (Oxford, England). PMID 31593590 DOI: 10.1093/Rheumatology/Kez457 |
0.544 |
|
| 2019 |
Coates LC, Strand V, Wilson H, Revicki D, Stolshek B, Samad A, Chung JB, Gladman D, Mease PJ. Measurement properties of the minimal disease activity criteria for psoriatic arthritis. Rmd Open. 5: e001002. PMID 31565243 DOI: 10.1136/Rmdopen-2019-001002 |
0.36 |
|
| 2019 |
Aydin SZ, Bakirci S, Kasapoglu E, Castillo-Gallego C, Alhussain FA, Ash ZR, Kurum E, McGonagle D, Marzo-Ortega H, Gladman D, Eder L. The relationship between physical examination and ultrasonography for large entheses is best for the Achilles tendon and patellar tendon origin. The Journal of Rheumatology. PMID 31474590 DOI: 10.3899/Jrheum.190169 |
0.482 |
|
| 2019 |
Colaco K, Ocampo V, Ayala AP, Harvey P, Gladman D, Piguet V, Eder L. Predictive utility of cardiovascular risk prediction algorithms in inflammatory rheumatic diseases: A systematic review. The Journal of Rheumatology. PMID 31416923 DOI: 10.3899/Jrheum.190261 |
0.478 |
|
| 2019 |
Chandran V, Cook RJ, Gladman DD. Response to: 'Can biomarkers differentiate psoriatic arthritis from osteoarthritis?' by Tian . Annals of the Rheumatic Diseases. PMID 31272941 DOI: 10.1136/Annrheumdis-2019-215762 |
0.467 |
|
| 2019 |
Perruccio AV, Got M, Li S, Ye Y, Gladman DD, Chandran V. Treating Psoriatic Arthritis to Target: Defining Psoriatic Arthritis Disease Activity Score (PASDAS) That Reflects State Of Minimal Disease Activity (MDA). The Journal of Rheumatology. PMID 31203221 DOI: 10.3899/Jrheum.181472 |
0.485 |
|
| 2019 |
Fei JZ, Perruccio AV, Ye JY, Gladman DD, Chandran V. The relationship between patient acceptable symptom state and disease activity in patients with psoriatic arthritis. Rheumatology (Oxford, England). PMID 31199486 DOI: 10.1093/Rheumatology/Kez202 |
0.513 |
|
| 2019 |
Sobchak C, Akhtari S, Harvey P, Gladman D, Chandran V, Cook R, Eder L. The value of carotid ultrasound in cardiovascular risk stratification in patients with psoriatic disease. Arthritis & Rheumatology (Hoboken, N.J.). PMID 31165591 DOI: 10.1002/Art.40925 |
0.664 |
|
| 2019 |
Leung YY, Orbai AM, Ogdie A, Coates LC, de Wit M, Callis Duffin K, Eder L, Gladman DD, Goel N, Mease PJ, Strand V, FitzGerald O, Tillett W. The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set. The Journal of Rheumatology. Supplement. 95: 33-37. PMID 31154402 DOI: 10.3899/Jrheum.190122 |
0.534 |
|
| 2019 |
Jadon DR, Chandran V, Ogdie A, Pennington SR, Stober C, Gladman DD, de Wit M, O'Sullivan D, Mease P, Armstrong AW, Callis Duffin K, Magee C, Helliwell P, Ritchlin CT, FitzGerald O. Proceedings of the 2018 GRAPPA Collaborative Research Network Meeting. The Journal of Rheumatology. Supplement. 95: 11-19. PMID 31154399 DOI: 10.3899/Jrheum.190118 |
0.44 |
|
| 2019 |
Gladman DD, Charles-Schoeman C, McInnes IB, Veale DJ, Thiers B, Nurmohamed M, Graham D, Wang C, Jones T, Wolk R, Demasi R. Changes in Lipid Levels and Incidence of Cardiovascular Events Following Tofacitinib Treatment in Patients with Psoriatic Arthritis: A Pooled Analysis Across Phase 3 and Long-Term Extension Studies. Arthritis Care & Research. PMID 31112005 DOI: 10.1002/acr.23930 |
0.306 |
|
| 2019 |
Johnson K, Ye JY, Chandran V, Gladman DD. A novel role for the psoriatic arhtirtis impact of disease (PsAID) questionnaire. Seminars in Arthritis and Rheumatism. PMID 31101369 DOI: 10.1016/J.Semarthrit.2019.04.001 |
0.52 |
|
| 2019 |
Patrick MT, Stuart PE, Raja K, Chi S, He Z, Voorhees JJ, Tejasvi T, Gudjonsson JE, Kahlenberg JM, Chandran V, Rahman P, Gladman DD, Nair RP, Elder JT, Tsoi LC. Integrative Approach to Reveal Cell Type Specificity and Gene Candidates for Psoriatic Arthritis Outside the MHC. Frontiers in Genetics. 10: 304. PMID 31031798 DOI: 10.3389/Fgene.2019.00304 |
0.446 |
|
| 2019 |
Chandran V, Abji F, Perruccio AV, Gandhi R, Li S, Cook RJ, Gladman DD. Serum-based soluble markers differentiate psoriatic arthritis from osteoarthritis. Annals of the Rheumatic Diseases. PMID 30910989 DOI: 10.1136/Annrheumdis-2018-214737 |
0.448 |
|
| 2019 |
Perruccio AV, Got M, Li S, Ye Y, Gladman DD, Chandran V. The development of a modified Psoriatic Arthritis Disease Activity Score (mPASDAS) using SF-12 as a measure of quality of life. Arthritis Care & Research. PMID 30875460 DOI: 10.1002/Acr.23876 |
0.512 |
|
| 2019 |
van der Heijde D, Gladman DD, FitzGerald O, Kavanaugh A, Graham D, Wang C, Fallon L. Radiographic Progression According to Baseline C-reactive Protein Levels and Other Risk Factors in Psoriatic Arthritis Patients Treated with Tofacitinib or Adalimumab. The Journal of Rheumatology. PMID 30824647 DOI: 10.3899/jrheum.180971 |
0.313 |
|
| 2019 |
Pollock RA, Zaman L, Chandran V, Gladman DD. Epigenome-wide analysis of sperm cells identifies IL22 as a possible germ line risk locus for psoriatic arthritis. Plos One. 14: e0212043. PMID 30779748 DOI: 10.1371/Journal.Pone.0212043 |
0.479 |
|
| 2019 |
Duarte-García A, Leung YY, Coates LC, Beaton D, Christensen R, Craig ET, de Wit M, Eder L, Fallon L, FitzGerald O, Gladman DD, Goel N, Holland R, Lindsay C, Maxwell L, et al. Endorsement of the 66/68 joint count for the measurement of musculoskeletal disease activity: OMERACT 2018 Psoriatic Arthritis workshop report. The Journal of Rheumatology. PMID 30770518 DOI: 10.3899/Jrheum.181089 |
0.542 |
|
| 2019 |
Smolen JS, Gladman D, McNeil HP, Mease PJ, Sieper J, Hojnik M, Nurwakagari P, Weinman J. Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study. Rmd Open. 5: e000585. PMID 30713716 DOI: 10.1136/Rmdopen-2017-000585 |
0.381 |
|
| 2019 |
Polachek A, Cook R, Chandran V, Gladman DD, Eder L. Correction to: The association between sonographic enthesitis and radiographic damage in psoriatic arthritis. Arthritis Research & Therapy. 21: 20. PMID 30642391 DOI: 10.1186/S13075-019-1814-1 |
0.577 |
|
| 2018 |
Chan J, Gladman D. Oral treatment options for AS and PsA: DMARDs and small-molecule inhibitors. Best Practice & Research. Clinical Rheumatology. 32: 415-426. PMID 31171312 DOI: 10.1016/J.Berh.2018.08.003 |
0.381 |
|
| 2018 |
Polachek A, Polachek Shlomi I, Spitzer K, Pereira D, Ye JY, Chandran V, Laskin CA, Gladman DD. Outcome of pregnancy in women with psoriatic arthritis compared to healthy controls. Clinical Rheumatology. PMID 30535992 DOI: 10.1007/S10067-018-4385-7 |
0.447 |
|
| 2018 |
Feld J, Chandran V, Gladman DD. What Is Axial Psoriatic Arthritis? The Journal of Rheumatology. 45: 1611-1613. PMID 30504477 DOI: 10.3899/Jrheum.180802 |
0.541 |
|
| 2018 |
Wakhlu A, Chandran V, Phumethum V, Shen H, Cook RJ, Gladman D. Comparison Between INSPIRE and Domjan method for measuring lumbar lateral flexion in patients of psoriatic arthritis (PsA) and correlation with radiographic damage. Clinical Rheumatology. PMID 30498874 DOI: 10.1007/S10067-018-4375-9 |
0.527 |
|
| 2018 |
Polachek A, Li S, Polachek IS, Chandran V, Gladman D. Corrigendum to "Psoriatic arthritis disease activity during pregnancy and the first-year postpartum" [Semin. Arthritis Rheum. 46 (6) (2017) 740-745]. Seminars in Arthritis and Rheumatism. PMID 30477737 DOI: 10.1016/J.Semarthrit.2018.11.001 |
0.532 |
|
| 2018 |
Elmamoun M, Leung YY, O'Sullivan D, Steinkoenig I, Chandran V, Gladman DD, FitzGerald OM, Orbai AM, Eder L. Using Acute-phase Reactants to Inform the Development of Instruments for the Updated Psoriatic Arthritis Core Outcome Measurement Set. The Journal of Rheumatology. PMID 30385708 DOI: 10.3899/Jrheum.180195 |
0.614 |
|
| 2018 |
Patrick MT, Stuart PE, Raja K, Gudjonsson JE, Tejasvi T, Yang J, Chandran V, Das S, Callis-Duffin K, Ellinghaus E, Enerbäck C, Esko T, Franke A, Kang HM, Krueger GG, ... ... Gladman DD, et al. Genetic signature to provide robust risk assessment of psoriatic arthritis development in psoriasis patients. Nature Communications. 9: 4178. PMID 30301895 DOI: 10.1038/S41467-018-06672-6 |
0.513 |
|
| 2018 |
Polachek A, Al-Johani R, Li S, Ye JY, Chandran V, Gladman D. Late onset psoriatic arthritis in a longitudinal cohort: Disease presentation, activity over time and prognosis. Seminars in Arthritis and Rheumatism. PMID 30243758 DOI: 10.1016/J.Semarthrit.2018.08.005 |
0.593 |
|
| 2018 |
Eder L, Widdifield J, Rosen CF, Cook R, Lee KA, Alhusayen R, Paterson JM, Cheng SY, Jabbari S, Campbell W, Bernatsky S, Gladman DD, Tu K. Trends in the prevalence and incidence of psoriasis and psoriatic arthritis in Ontario, Canada: A population-based study. Arthritis Care & Research. PMID 30171803 DOI: 10.1002/Acr.23743 |
0.507 |
|
| 2018 |
Yap KS, Ye JY, Li S, Gladman DD, Chandran V. Back pain in psoriatic arthritis: defining prevalence, characteristics and performance of inflammatory back pain criteria in psoriatic arthritis. Annals of the Rheumatic Diseases. PMID 30077991 DOI: 10.1136/Annrheumdis-2018-213334 |
0.443 |
|
| 2018 |
Zhou W, Chandran V, Cook R, Gladman DD, Eder L. The association between occupational-related mechanical stress and radiographic damage in psoriatic arthritis. Seminars in Arthritis and Rheumatism. PMID 30057322 DOI: 10.1016/J.Semarthrit.2018.06.001 |
0.643 |
|
| 2018 |
Alinaghi F, Calov M, Kristensen LE, Gladman DD, Coates LC, Jullien D, Gottlieb AB, Gisondi P, Wu JJ, Thyssen JP, Egeberg A. Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies. Journal of the American Academy of Dermatology. PMID 29928910 DOI: 10.1016/j.jaad.2018.06.027 |
0.306 |
|
| 2018 |
Warren RB, Reich K, Langley RG, Strober B, Gladman D, Deodhar A, Bachhuber T, Bao W, Altemeyer E, Hussain S, Safi J. Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database. The British Journal of Dermatology. PMID 29927479 DOI: 10.1111/Bjd.16901 |
0.318 |
|
| 2018 |
Jadon DR, Chandran V, Stober C, Ogdie A, Armstrong AW, Callis Duffin K, Gladman DD, Helliwell PS, O'Sullivan D, de Wit M, FitzGerald O, Ritchlin CT. Proceedings of the 2017 GRAPPA Collaborative Research Network Meeting. The Journal of Rheumatology. Supplement. 94: 54-61. PMID 29858357 DOI: 10.3899/Jrheum.180141 |
0.468 |
|
| 2018 |
Holland R, Tillett W, Ogdie A, Leung YY, Gladman DD, Callis Duffin K, Coates LC, Mease PJ, Eder L, Strand V, Elmamoun M, Højgaard P, Chau J, de Wit M, Goel N, et al. Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting. The Journal of Rheumatology. Supplement. 94: 17-25. PMID 29858348 DOI: 10.3899/Jrheum.180142 |
0.536 |
|
| 2018 |
Feld J, Chandran V, Haroon N, Inman R, Gladman D. Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison. Nature Reviews. Rheumatology. PMID 29752461 DOI: 10.1038/S41584-018-0006-8 |
0.605 |
|
| 2018 |
Chandran V, Stecher L, Farewell V, Gladman DD. Patterns of peripheral joint involvement in psoriatic arthritis-Symmetric, ray and/or row? Seminars in Arthritis and Rheumatism. PMID 29724452 DOI: 10.1016/J.Semarthrit.2018.03.002 |
0.438 |
|
| 2018 |
Tselios K, Gladman DD, Harvey P, Su J, Urowitz MB. Severe brady-arrhythmias in systemic lupus erythematosus: prevalence, etiology and associated factors. Lupus. 961203318770526. PMID 29665757 DOI: 10.1177/0961203318770526 |
0.307 |
|
| 2018 |
Tanwani J, Tselios K, Gladman DD, Su J, Urowitz MB. Lupus myocarditis: a single center experience and a comparative analysis of observational cohort studies. Lupus. 961203318770018. PMID 29642752 DOI: 10.1177/0961203318770018 |
0.316 |
|
| 2018 |
van der Heijde D, Deodhar A, FitzGerald O, Fleischmann R, Gladman D, Gottlieb AB, Hoepken B, Bauer L, Irvin-Sellers O, Khraishi M, Peterson L, Turkiewicz A, Wollenhaupt J, Mease PJ. 4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis. Rmd Open. 4: e000582. PMID 29556416 DOI: 10.1136/Rmdopen-2017-000582 |
0.383 |
|
| 2018 |
Mease P, Gladman D. Tofacitinib for Psoriatic Arthritis. The New England Journal of Medicine. 378: 775-776. PMID 29466165 DOI: 10.1056/Nejmc1715189 |
0.375 |
|
| 2018 |
Eder L, Harvey P, Chandran V, Rosen CF, Dutz J, Elder JT, Rahman P, Ritchlin CT, Rohekar S, Hayday R, Barac S, Feld J, Zisman D, Gladman DD. Gaps in Diagnosis and Treatment of Cardiovascular Risk Factors in Patients with Psoriatic Disease: An International Multicenter Study. The Journal of Rheumatology. PMID 29419462 DOI: 10.3899/Jrheum.170379 |
0.657 |
|
| 2018 |
Polachek A, Cook R, Chandran V, Abji F, Gladman D, Eder L. The Association between HLA Genetic Susceptibility Markers and Sonographic Enthesitis in Psoriatic Arthritis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 29361203 DOI: 10.1002/Art.40423 |
0.652 |
|
| 2018 |
Keeling S, Alabdurubalnabi Z, Avina-Zubieta A, Barr S, Bergeron L, Bernatsky S, Bourre-Tessier J, Clarke A, Baril-Dionne A, Dutz J, Ensworth S, Fifi-Mah A, Fortin PR, Gladman D, Haaland D, et al. CS-36 Recommendations for the assessment of systemic lupus erythematosus in canada Lupus Science & Medicine. 5. DOI: 10.1136/Lupus-2018-Lsm.71 |
0.396 |
|
| 2018 |
Urowitz M, Gladman D, Su J, Anderson N, Touma Z. S1D:5 Sle disease activity index glucocorticosteroid index (sledai-2kg) identifies more responders than sledai-2k Lupus Science & Medicine. 5. DOI: 10.1136/Lupus-2018-Abstract.5 |
0.318 |
|
| 2018 |
Eudy A, Petri M, Fischer-Betz R, Mokbel A, Nalli C, Andreoli L, Tincani A, Molad Y, Gladman D, Urowitz M. PS4:80 Hydroxychloroquine in lupus pregnancy: a meta-analysis of individual participant data Lupus Science & Medicine. 5. DOI: 10.1136/Lupus-2018-Abstract.125 |
0.308 |
|
| 2018 |
Johnson K, Ye J, Chandran V, Gladman D. THU0301 A novel role for the psoriatic arthritis impact of disease questionnaire (PSAID) Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2018-Eular.6751 |
0.541 |
|
| 2018 |
Tselios K, Gladman D, Touma Z, Su J, Anderson N, Urowitz M. SAT0451 Disease course patterns in systemic lupus erythematosus Annals of the Rheumatic Diseases. 77: 1085-1085. DOI: 10.1136/Annrheumdis-2018-Eular.5680 |
0.39 |
|
| 2018 |
Touma Z, Gladman D, Su J, Anderson NM, Urowitz MB. FRI0395 Sle disease activity index glucocorticoid index (SLEDAI-2KG) identifies more responders than sledai-2k Annals of the Rheumatic Diseases. 77: 730-731. DOI: 10.1136/Annrheumdis-2018-Eular.5519 |
0.319 |
|
| 2018 |
Helliwell P, Favier G, Gladman D, Soriano E, Kirkham B, Coates L, Puig L, Boehncke W-, Thaci D. SAT0345 Quality indicators in the care of psoriatic arthritis Annals of the Rheumatic Diseases. 77: 1038-1038. DOI: 10.1136/Annrheumdis-2018-Eular.4292 |
0.344 |
|
| 2018 |
Deodhar A, Gladman D, McInnes I, Ren M, Spindeldreher S, Pricop L, Porter B, Safi J, Shete A, Bruin G. SAT0271 Secukinumab, a fully human anti-interleukin-17a monoclonal antibody, exhibits low immunogenicity in patients with psoriatic arthritis and ankylosing spondylitis during a 52-week treatment period Annals of the Rheumatic Diseases. 77: 999-1000. DOI: 10.1136/Annrheumdis-2018-Eular.3646 |
0.314 |
|
| 2018 |
Mease P, Gladman D, Kavanaugh A, Nakasato P, Guerette B, Teng L, Nash P. OP0309 Characterisation of clinical benefits in subjects classified as acr20 non-responders at week 104 of apremilast treatment: subanalysis of 3 long-term, phase iii trials Annals of the Rheumatic Diseases. 77: 201-202. DOI: 10.1136/Annrheumdis-2018-Eular.2705 |
0.337 |
|
| 2018 |
Heijde Dvd, Deodhar A, FitzGerald O, Fleischmann R, Gladman D, Gottlieb AB, Coates LC, Hoepken B, Bauer L, Peterson L, Khraishi M, Mease PJ. SAT0324 Certolizumab pegol provides sustained remission and minimal disease activity in patients with psoriatic arthritis over 4 years’ treatment Annals of the Rheumatic Diseases. 77: 1027-1027. DOI: 10.1136/Annrheumdis-2018-Eular.2637 |
0.365 |
|
| 2018 |
Coates L, Alonso E, Baraliakos X, Garcia FB, Braun J, Chandran V, Fernandez-Sueiro JL, FitzGerald O, Gallagher P, Gladman D, Gubar E, Korotaeva T, Loginova E, Lubrano E, Mulero J, et al. OP0128 The phenotype of axial psoriatic arthritis: is it dependent on hla-b27 status? Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2018-Eular.1832 |
0.303 |
|
| 2018 |
Coates LC, Gladman D, Nash P, Fitzgerald O, Kavanaugh A, Rasouliyan L, Pricop L, Ding K, Gaillez C. 171 Secukinumab provides sustained PASDAS related low disease activity in psoriatic arthritis: two year results from the FUTURE 2 study Rheumatology. 57. DOI: 10.1093/Rheumatology/Key075.395 |
0.378 |
|
| 2018 |
Chinoy H, Gossec L, Kvien TK, Conaghan PG, Østergaard M, Gladman D, Mease P, Rasouliyan L, Pricop L, Gaillez C, Jugl S. 169 Secukinumab provides sustained reduction in fatigue in patients with active psoriatic arthritis through three years: long-term data from the FUTURE 1 and FUTURE 2 studies Rheumatology. 57. DOI: 10.1093/Rheumatology/Key075.393 |
0.345 |
|
| 2018 |
Patrick M, Stuart P, Raja K, Yang J, Zawistowski M, Voorhees J, Tejasvi T, Gudjonsson J, Chandran V, Rahman P, Nair R, Gladman D, Elder J, Tsoi L. 746 Challenges and opportunities for integrating genetics and health records in risk assessment for psoriasis subtypes Journal of Investigative Dermatology. 138: S127. DOI: 10.1016/J.Jid.2018.03.756 |
0.393 |
|
| 2017 |
Mease PJ, Kavanaugh A, Coates LC, McInnes IB, Hojnik M, Zhang Y, Anderson JK, Dorr AP, Gladman DD. Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trial. Rmd Open. 3: e000415. PMID 29225916 DOI: 10.1136/rmdopen-2016-000415 |
0.335 |
|
| 2017 |
AlJohani R, Polachek A, Ye JY, Chandran V, Gladman DD. Characteristic and Outcome of Psoriatic Arthritis Patients with Hyperuricemia. The Journal of Rheumatology. PMID 29196385 DOI: 10.3899/Jrheum.170384 |
0.516 |
|
| 2017 |
Patel P, Rosen CF, Chandran V, Ye YJ, Gladman DD. Addressing comorbidities in psoriatic disease. Rheumatology International. PMID 29185085 DOI: 10.1007/S00296-017-3895-Y |
0.509 |
|
| 2017 |
Abji F, Pollock RA, Liang K, Chandran V, Gladman DD. Th17 gene expression in psoriatic arthritis synovial fluid and peripheral blood compared to osteoarthritis and cutaneous psoriasis. Clinical and Experimental Rheumatology. PMID 29148410 |
0.448 |
|
| 2017 |
Eder L, Joshi AA, Dey AK, Cook R, Siegel EL, Gladman DD, Mehta NN. TNF-α inhibitors are associated with reduced indices of subclinical atherosclerosis in patients with psoriatic disease. Arthritis & Rheumatology (Hoboken, N.J.). PMID 29088580 DOI: 10.1002/Art.40366 |
0.526 |
|
| 2017 |
Gladman D, Rigby W, Azevedo VF, Behrens F, Blanco R, Kaszuba A, Kudlacz E, Wang C, Menon S, Hendrikx T, Kanik KS. Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors. The New England Journal of Medicine. 377: 1525-1536. PMID 29045207 DOI: 10.1056/Nejmoa1615977 |
0.37 |
|
| 2017 |
Højgaard P, Klokker L, Orbai AM, Holmsted K, Bartels EM, Leung YY, Goel N, de Wit M, Gladman DD, Mease P, Dreyer L, Kristensen LE, FitzGerald O, Tillett W, Gossec L, et al. A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative. Seminars in Arthritis and Rheumatism. PMID 29037523 DOI: 10.1136/Annrheumdis-2017-Eular.4631 |
0.318 |
|
| 2017 |
Dand N, Mucha S, Tsoi LC, Mahil SK, Stuart PE, Arnold A, Baurecht H, Burden AD, Duffin KC, Chandran V, Curtis CJ, Das S, Ellinghaus D, Ellinghaus E, Enerback C, ... ... Gladman DD, et al. Exome-wide association study reveals novel psoriasis susceptibility locus at TNFSF15 and rare protective alleles in genes contributing to type I IFN signalling. Human Molecular Genetics. PMID 28973304 DOI: 10.1093/Hmg/Ddx328 |
0.413 |
|
| 2017 |
Polachek A, Cook R, Chandran V, Gladman DD, Eder L. The association between sonographic enthesitis and radiographic damage in psoriatic arthritis. Arthritis Research & Therapy. 19: 189. PMID 28810926 DOI: 10.1186/S13075-017-1399-5 |
0.629 |
|
| 2017 |
Berinstein J, Pollock R, Pellett F, Thavaneswaran A, Chandran V, Gladman DD. Association of variably expressed KIR3dl1 alleles with psoriatic disease. Clinical Rheumatology. PMID 28801811 DOI: 10.1007/S10067-017-3784-5 |
0.474 |
|
| 2017 |
Deeb M, Tselios K, Gladman DD, Su J, Urowitz MB. Shrinking lung syndrome in systemic lupus erythematosus: a single-centre experience. Lupus. 961203317722411. PMID 28758573 DOI: 10.1177/0961203317722411 |
0.341 |
|
| 2017 |
Maldonado-Ficco H, Sheane BJ, Thavaneswaran A, Chandran V, Gladman DD. Magnetic Resonance Imaging in Psoriatic Arthritis: A Descriptive Study of Indications, Features and Effect on Treatment Change. Journal of Clinical Rheumatology : Practical Reports On Rheumatic & Musculoskeletal Diseases. PMID 28700527 DOI: 10.1097/Rhu.0000000000000558 |
0.393 |
|
| 2017 |
Wong ITY, Chandran V, Li S, Gladman DD. Sleep Disturbance in Psoriatic Disease: Prevalence and Associated Factors. The Journal of Rheumatology. PMID 28620064 DOI: 10.3899/Jrheum.161330 |
0.411 |
|
| 2017 |
Gladman DD, Poulin Y, Adams K, Bourcier M, Barac S, Barber K, Chandran V, Dutz J, Flanagan C, Gooderham MJ, Gulliver WP, Ho VC, Hong CH, Karsh J, Khraishi MM, et al. Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice. The Journal of Rheumatology. 44: 519-534. PMID 28604347 DOI: 10.3899/Jrheum.161473 |
0.431 |
|
| 2017 |
Aljohani R, Gladman DD, Su J, Urowitz MB. Comparison of systemic lupus erythematosus (SLE) patients managed early after diagnosis in specialty versus community care clinics. Clinical Rheumatology. PMID 28589322 DOI: 10.1007/S10067-017-3713-7 |
0.325 |
|
| 2017 |
Tsoi LC, Stuart PE, Tian C, Gudjonsson JE, Das S, Zawistowski M, Ellinghaus E, Barker JN, Chandran V, Dand N, Duffin KC, Enerbäck C, Esko T, Franke A, Gladman DD, et al. Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants. Nature Communications. 8: 15382. PMID 28537254 DOI: 10.1038/Ncomms15382 |
0.415 |
|
| 2017 |
Ogdie A, de Wit M, Callis Duffin K, Campbell W, Chau J, Coates LC, Eder L, Elmamoun M, FitzGerald O, Gladman DD, Goel N, James J, Kalyoncu U, Latella J, Lindsay C, et al. Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group. The Journal of Rheumatology. 44: 697-700. PMID 28461531 DOI: 10.3899/Jrheum.170150 |
0.508 |
|
| 2017 |
Jadon DR, Gladman DD, Mease PJ, FitzGerald O, Chandran V, Goel N, Rosen CF, Maksymowych WP, Ritchlin CT, Ogdie A, Coates LC, Cauli A, Soriano ER, Husni ME, Campbell W, et al. Proceedings of the GRAPPA 2016 Retreat. The Journal of Rheumatology. 44: 668-673. PMID 28461522 DOI: 10.3899/Jrheum.170141 |
0.446 |
|
| 2017 |
Isenberg D, Sturgess J, Allen E, Aranow C, Askanase A, Sang-Cheol B, Bernatsky S, Bruce I, Buyon J, Cervera R, Clarke A, Dooley MA, Fortin P, Ginzler E, Gladman D, et al. A study of flare assessment in systemic lupus erythematosus (SLE) based on paper patients. Arthritis Care & Research. PMID 28388813 DOI: 10.1002/Acr.23252 |
0.378 |
|
| 2017 |
Eder L, Abji F, Rosen CF, Chandran V, Gladman DD. The Association Between Obesity and Clinical Features of Psoriatic Arthritis: A Case-control Study. The Journal of Rheumatology. PMID 28202737 DOI: 10.3899/Jrheum.160532 |
0.603 |
|
| 2017 |
Polachek A, Li S, Polachek IS, Chandran V, Gladman D. Psoriatic arthritis disease activity during pregnancy and the first-year postpartum. Seminars in Arthritis and Rheumatism. PMID 28196621 DOI: 10.1016/J.Semarthrit.2017.01.002 |
0.548 |
|
| 2017 |
Tselios K, Yap KS, Pakchotanon R, Polachek A, Su J, Urowitz MB, Gladman DD. Psoriasis in systemic lupus erythematosus: a single-center experience. Clinical Rheumatology. PMID 28168661 DOI: 10.1007/S10067-017-3566-0 |
0.327 |
|
| 2017 |
Orbai AM, de Wit M, Mease PJ, Callis Duffin K, Elmamoun M, Tillett W, Campbell W, FitzGerald O, Gladman DD, Goel N, Gossec L, Hoejgaard P, Leung YY, Lindsay C, Strand V, et al. Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016. The Journal of Rheumatology. PMID 28148697 DOI: 10.3899/Jrheum.160904 |
0.515 |
|
| 2017 |
Eder L, Chandran V, Cook R, Gladman DD. The Risk of Developing Diabetes Mellitus in Patients with Psoriatic Arthritis: A Cohort Study. The Journal of Rheumatology. PMID 28148695 DOI: 10.3899/Jrheum.160861 |
0.635 |
|
| 2017 |
Ibrahim A, Gladman DD, Thavaneswaran A, Eder L, Helliwell P, Cook RJ, Chandran V. Radiographic scoring instruments have moderate sensitivity but high specificity for detecting change in axial psoriatic arthritis. Arthritis Care & Research. PMID 28085226 DOI: 10.1002/Acr.23189 |
0.623 |
|
| 2017 |
Choi M, Clarke A, Pierre YS, Hanly J, Urowitz M, Gladman D, Pike S, Fritzler M. 400 Ana-negative sle: re-evaluation in an international inception cohort Lupus Science & Medicine. 4. DOI: 10.1136/Lupus-2017-000215.400 |
0.316 |
|
| 2017 |
Tselios K, Gladman D, Harvey P, Su J, Urowitz M. 177 Association between chronic antimalarial therapy and elevated myocardial biomarkers in patients with systemic lupus erythematosus and no prior heart disease: a preliminary report Lupus Science & Medicine. 4. DOI: 10.1136/Lupus-2017-000215.177 |
0.371 |
|
| 2017 |
Urowitz M, Gladman D, Su J, Anderson N. 176 Accrual of disease comorbidities over 8 years in a multicentre inception sle cohort Lupus Science & Medicine. 4. DOI: 10.1136/Lupus-2017-000215.176 |
0.367 |
|
| 2017 |
Touma Z, Gladman D, Su J, Urowitz M. 11 Development and initial validation of a novel lupus disease activity index to account for glucocorticoids: SLEDAI-2K glucocorticoids index (SGI) Lupus Science & Medicine. 4. DOI: 10.1136/Lupus-2017-000215.11 |
0.324 |
|
| 2017 |
Fei J, Perruccio A, Ye Y, Gladman D, Chandran V. SAT0481 The relationship between the patient acceptable symptom state (PASS) and disease activity in patients with psoriatic arthritis (PSA) Annals of the Rheumatic Diseases. 76: 957-957. DOI: 10.1136/Annrheumdis-2017-Eular.6186 |
0.585 |
|
| 2017 |
Polachek A, Cook R, Chandran V, Gladman D, Eder L. OP0111 The association between sonographic enthesitis and radiographic joint damage in psoriatic arthritis Annals of the Rheumatic Diseases. 76: 98-98. DOI: 10.1136/Annrheumdis-2017-Eular.5007 |
0.61 |
|
| 2017 |
Zhou W, Cook R, Chandran V, Gladman D, Eder L. FRI0522 The association between occupational-related mechanical stress and radiographic damage in psoriatic arthritis Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2017-Eular.4074 |
0.531 |
|
| 2017 |
Mease P, Gladman D, Gomez-Reino J, Hall S, Kavanaugh A, Lespessailles E, Schett G, Paris M, Teng L, Wollenhaupt J. AB0785 Consistent safety profile with up to 4 years of apremilast treatment: analysis of data from 1493 patients with psoriatic arthritis in 3 large, phase iii, long-term studies Annals of the Rheumatic Diseases. 76: 1331-1332. DOI: 10.1136/Annrheumdis-2017-Eular.3840 |
0.34 |
|
| 2017 |
Smolen J, Aletaha D, Gladman D, Zhang Y, Ganz F. FRI0498 Outcomes associated with achievement of various treatment targets in patients with psoriatic arthritis receiving adalimumab Annals of the Rheumatic Diseases. 76: 677-677. DOI: 10.1136/Annrheumdis-2017-Eular.3762 |
0.403 |
|
| 2017 |
Kavanaugh A, Gladman D, Gomez-Reino J, Hall S, Lespessailles E, Mease P, Schett G, McIlraith M, Delev N, Paris M, Teng L, Wollenhaupt J. SAT0436 Durability of apremilast response in patients with psoriatic arthritis: long-term (208-week) results from the palace 1 trial Annals of the Rheumatic Diseases. 76: 936-937. DOI: 10.1136/Annrheumdis-2017-Eular.3001 |
0.321 |
|
| 2017 |
Mease P, Gottlieb A, Heijde Dvd, FitzGerald O, Johnsen A, Nys M, Banerjee S, Gladman D. Abatacept in the Treatment of Active Psoriatic Arthritis: 1-Year Results From a Phase III Study Annals of the Rheumatic Diseases. 76: 145-146. DOI: 10.1136/Annrheumdis-2017-Eular.2865 |
0.308 |
|
| 2017 |
Strand V, Vlam Kd, Covarrubias-Cobos J, Mease P, Gladman D, Hendrikx T, Kudlacz E, Graham D, Wu J, Chen L. AB0794 Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis: results from two phase 3 studies Annals of the Rheumatic Diseases. 76: 1335-1336. DOI: 10.1136/Annrheumdis-2017-Eular.2445 |
0.333 |
|
| 2017 |
Gladman D, Rigby W, Azevedo V, Behrens F, Blanco R, Kaszuba A, Kudlacz E, Wang C, Menon S, Hendrikx T, Kanik K. OP0202 Efficacy and safety of tofacitinib, an oral janus kinase inhibitor, in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: opal beyond, a randomised, double-blind, placebo-controlled, phase 3 trial Annals of the Rheumatic Diseases. 76: 135-136. DOI: 10.1136/Annrheumdis-2017-Eular.2443 |
0.328 |
|
| 2017 |
FitzGerald O, Fleischmann R, Kavanaugh A, Hoepken B, Peterson L, Gladman D. FRI0508 The effect of certolizumab pegol on extra-articular manifestations of psoriatic arthritis over 4 years of treatment in patients with and without prior anti-tnf exposure Annals of the Rheumatic Diseases. 76: 681-681. DOI: 10.1136/Annrheumdis-2017-Eular.1969 |
0.333 |
|
| 2017 |
Gladman D, Fleischmann R, Harris K, Peterson L, Mease P. FRI0489 Certolizumab pegol is associated with long-term improvements in patient-reported outcomes in psoriatic arthritis: 4-year outcomes from the rapid-psa study Annals of the Rheumatic Diseases. 76: 673-673. DOI: 10.1136/Annrheumdis-2017-Eular.1654 |
0.376 |
|
| 2017 |
Nash P, Coates L, Kivitz A, Mease P, Gladman D, Covarrubias-Cobos J, Fleishaker D, Wang C, Kudlacz E, Menon S, Hendrikx T, Kanik K. FRI0509 Safety and efficacy of tofacitinib, an oral janus kinase inhibitor, up to 24 months in patients with active psoriatic arthritis: interim data from opal balance, an open-label, long-term extension study Annals of the Rheumatic Diseases. 76: 682-682. DOI: 10.1136/Annrheumdis-2017-Eular.1414 |
0.316 |
|
| 2017 |
Mease P, Okada M, Kishimoto M, Shuler C, Carlier H, Lin C, Mou J, Moriarty S, Lee C, Gladman D, Satler M. 397 Fifty two-week efficacy and safety results from SPIRIT-P1: A Phase 3 study of ixekizumab in patients with active psoriatic arthritis Journal of Investigative Dermatology. 137: S260. DOI: 10.1016/J.Jid.2017.07.592 |
0.331 |
|
| 2016 |
Polachek A, Li S, Chandran V, Gladman D. Clinical enthesitis in a prospective longitudinal psoriatic arthritis cohort: Incidence, prevalence, characteristics and outcome. Arthritis Care & Research. PMID 27998023 DOI: 10.1002/Acr.23174 |
0.494 |
|
| 2016 |
Muntyanu A, Abji F, Liang K, Pollock RA, Chandran V, Gladman DD. Differential gene and protein expression of chemokines and cytokines in synovial fluid of patients with arthritis. Arthritis Research & Therapy. 18: 296. PMID 27964744 DOI: 10.1186/S13075-016-1196-6 |
0.488 |
|
| 2016 |
Eder L, Polachek A, Rosen CF, Chandran V, Cook R, Gladman DD. The development of PsA in patients with psoriasis is preceded by a period of non-specific musculoskeletal symptoms: A prospective cohort study. Arthritis & Rheumatology (Hoboken, N.J.). PMID 27792862 DOI: 10.1002/Art.39973 |
0.652 |
|
| 2016 |
Orbai AM, de Wit M, Mease P, Shea JA, Gossec L, Leung YY, Tillett W, Elmamoun M, Callis Duffin K, Campbell W, Christensen R, Coates L, Dures E, Eder L, FitzGerald O, ... Gladman D, et al. International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. Annals of the Rheumatic Diseases. PMID 27613807 DOI: 10.1136/Annrheumdis-2016-210242 |
0.526 |
|
| 2016 |
Eder L, Abji F, Rosen CF, Chandran V, Cook RJ, Gladman DD. The Association of HLA-class I Genes and the Extent of Atherosclerotic Plaques in Patients with Psoriatic Disease. The Journal of Rheumatology. PMID 27585683 DOI: 10.3899/Jrheum.151469 |
0.655 |
|
| 2016 |
Sheane BJ, Thavaneswaran A, Gladman DD, Chandran V. Attainment of Minimal Disease Activity Using Methotrexate in Psoriatic Arthritis. The Journal of Rheumatology. PMID 27422895 DOI: 10.3899/Jrheum.160111 |
0.503 |
|
| 2016 |
Abji F, Pollock RA, Liang K, Chandran V, Gladman DD. C-X-C Motif Chemokine 10 is a Possible Biomarker for the Development of Psoriatic Arthritis among Patients with Psoriasis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 27389865 DOI: 10.1002/Art.39800 |
0.461 |
|
| 2016 |
Orbai AM, Mease PJ, de Wit M, Kalyoncu U, Campbell W, Tillett W, Eder L, Elmamoun M, FitzGerald O, Gladman DD, Goel N, Gossec L, Lindsay CA, Steinkoenig I, Helliwell PS, et al. Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting. The Journal of Rheumatology. 43: 965-9. PMID 27134271 DOI: 10.3899/Jrheum.160116 |
0.514 |
|
| 2016 |
Touma Z, Thavaneswaran A, Chandran V, Pellett F, Cook RJ, Gladman DD. Clinical and Demographic Characteristics of Erosion-free and Erosion-present Status in Psoriatic Arthritis in a Cohort Study. The Journal of Rheumatology. PMID 27036389 DOI: 10.3899/Jrheum.150466 |
0.551 |
|
| 2016 |
Haddad A, Li S, Thavaneswaran A, Cook RJ, Chandran V, Gladman DD. The Incidence and Predictors of Infection in Psoriasis and Psoriatic Arthritis: Results from Longitudinal Observational Cohorts. The Journal of Rheumatology. PMID 26773102 DOI: 10.3899/Jrheum.140067 |
0.509 |
|
| 2016 |
Choi M, Clarke A, Hanly JG, Urowitz M, Romero-Diaz J, Gordon C, Bae S, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Fortin PR, Gladman D, et al. CE-21 The prevalence and determinants of ANTI-DFS70 antibodies in an international inception cohort of systemic lupus erythematosus (SLE) patients Lupus Science & Medicine. 3. DOI: 10.1136/Lupus-2016-000179.100 |
0.338 |
|
| 2016 |
Chandran V, Got M, Li S, Perruccio A, Gladman D. FRI0477 A Modified Version of The Psoriatic Arthritis Disease Activity Score (MPASDAS) Using Sf-12 as A Measure of Quality of Life May Be More Feasible in Clinical Practice Annals of the Rheumatic Diseases. 75: 611.1-611. DOI: 10.1136/Annrheumdis-2016-Eular.3677 |
0.533 |
|
| 2016 |
Chandran V, Perruccio A, Li S, Abji F, Gandhi R, Gladman D. THU0421 Serum-Based Soluble Markers May Differentiate Psoriatic Arthritis from Osteoarthritis Annals of the Rheumatic Diseases. 75: 341.2-342. DOI: 10.1136/Annrheumdis-2016-Eular.3644 |
0.481 |
|
| 2016 |
Mease PJ, Fleischmann R, Wollenhaupt J, Deodhar A, Gladman D, Hoepken B, Peterson L, Heijde Dvd. FRI0472 Improvements in Joint Outcomes of Psoriatic Arthritis over 4 Years of Treatment with Certolizumab Pegol in Patients with and without Prior Anti-TNF Exposure Annals of the Rheumatic Diseases. 75: 609-609. DOI: 10.1136/Annrheumdis-2016-Eular.3205 |
0.339 |
|
| 2016 |
Mease PJ, Fleischmann R, Wollenhaupt J, Deodhar A, Gladman D, Hoepken B, Peterson L, Heijde Dvd. FRI0471 Certolizumab Pegol for The Treatment of Psoriatic Arthritis: 4-Year Outcomes from The Rapid-Psa Trial Annals of the Rheumatic Diseases. 75: 608-609. DOI: 10.1136/Annrheumdis-2016-Eular.3192 |
0.323 |
|
| 2016 |
Eder L, Polachek A, Rosen C, Chandran V, Gladman D. THU0444 Subclinical Ultrasonographic Enthesitis in Patients with Psoriasis Is Associated with Risk Markers for Psoriatic Arthritis Annals of the Rheumatic Diseases. 75: 352.1-352. DOI: 10.1136/Annrheumdis-2016-Eular.1848 |
0.664 |
|
| 2016 |
Eder L, Chandran V, Cook R, Gladman D. THU0424 Treatment with Tnf Alpha Blockers Is Associated with Reduced Progression of Atherosclerotic Plaques in Patients with Psoriatic Disease – A Prospective Study Annals of the Rheumatic Diseases. 75: 343.1-343. DOI: 10.1136/Annrheumdis-2016-Eular.1843 |
0.683 |
|
| 2016 |
Gladman D, Fleischmann R, Harris K, Peterson L, Mease P. Certolizumab Pegol is Associated with Long-Term Improvements in Patient-Reported Outcomes in Psoriatic Arthritis: 4-Year Outcomes from the Rapid-Psa Study Value in Health. 19: A594. DOI: 10.1016/J.Jval.2016.09.1426 |
0.336 |
|
| 2016 |
Kavanaugh A, Gladman D, van der Heijde D, Purcaru O, Mease P. Long-Term Improvements in Workplace and Household Productivity and Social Participation Over 4 Years of Certolizumab Pegol Treatment in Patients with Psoriatic Arthritis, with and without Prior Anti-Tnf Exposure Value in Health. 19: A545. DOI: 10.1016/J.Jval.2016.09.1151 |
0.312 |
|
| 2015 |
Stuart PE, Nair RP, Tsoi LC, Tejasvi T, Das S, Kang HM, Ellinghaus E, Chandran V, Callis-Duffin K, Ike R, Li Y, Wen X, Enerbäck C, Gudjonsson JE, Kõks S, ... ... Gladman DD, et al. Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture. American Journal of Human Genetics. PMID 26626624 DOI: 10.1016/J.Ajhg.2015.10.019 |
0.447 |
|
| 2015 |
Eder L, Haddad A, Rosen CF, Lee KA, Chandran V, Cook R, Gladman DD. The incidence and risk factors for psoriatic arthritis in patients with psoriasis - a prospective cohort study. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26555117 DOI: 10.1002/Art.39494 |
0.655 |
|
| 2015 |
Eder L, Wu Y, Chandran V, Cook R, Gladman DD. Incidence and predictors for cardiovascular events in patients with psoriatic arthritis. Annals of the Rheumatic Diseases. PMID 26493817 DOI: 10.1136/Annrheumdis-2015-207980 |
0.657 |
|
| 2015 |
Eder L, Gladman DD. Atherosclerosis in psoriatic disease: latest evidence and clinical implications. Therapeutic Advances in Musculoskeletal Disease. 7: 187-95. PMID 26425147 DOI: 10.1177/1759720X15591801 |
0.564 |
|
| 2015 |
Pollock RA, Thavaneswaran A, Pellett F, Chandran V, Petronis A, Rahman P, Gladman DD. Further Evidence Supporting a Parent-of-Origin Effect in Psoriatic Disease. Arthritis Care & Research. 67: 1586-90. PMID 26017758 DOI: 10.1002/Acr.22625 |
0.466 |
|
| 2015 |
Kaka H, Ayearst R, Tran M, Touma Z, Bagovich M, Vinik O, Somaily M, Haddad A, Gladman DD, Chandran V. DEVELOPING AN IPAD® APPLICATION FOR DATA COLLECTION IN A RHEUMATOLOGY RESEARCH CLINIC. International Journal of Technology Assessment in Health Care. 31: 99-102. PMID 25991410 DOI: 10.1017/S0266462315000069 |
0.385 |
|
| 2015 |
Tsoi LC, Spain SL, Ellinghaus E, Stuart PE, Capon F, Knight J, Tejasvi T, Kang HM, Allen MH, Lambert S, Stoll SW, Weidinger S, Gudjonsson JE, Koks S, Kingo K, ... ... Gladman DD, et al. Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci. Nature Communications. 6: 7001. PMID 25939698 DOI: 10.1038/Ncomms8001 |
0.411 |
|
| 2015 |
Tillett W, Eder L, Goel N, De Wit M, Gladman DD, FitzGerald O, Campbell W, Helliwell PS, Gossec L, Orbai AM, Ogdie A, Strand V, McHugh NJ, Mease PJ. Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014. The Journal of Rheumatology. PMID 25934828 DOI: 10.3899/Jrheum.141156 |
0.537 |
|
| 2015 |
Tom BD, Chandran V, Farewell VT, Rosen CF, Gladman DD. Validation of the Toronto Psoriatic Arthritis Screen Version 2 (ToPAS 2). The Journal of Rheumatology. 42: 841-6. PMID 25834198 DOI: 10.3899/Jrheum.140857 |
0.442 |
|
| 2015 |
Kavanaugh A, van der Heijde D, Beutler A, Gladman D, Mease P, Krueger GG, McInnes IB, Helliwell P, Coates LC, Xu S. Patients with psoriatic arthritis who achieve minimal disease activity in response to golimumab therapy demonstrate less radiographic progression: Results through 5 years of the randomized, placebo-controlled, GO-REVEAL study. Arthritis Care & Research. PMID 25779603 DOI: 10.1002/Acr.22576 |
0.42 |
|
| 2015 |
Rohekar S, Chan J, Tse SM, Haroon N, Chandran V, Bessette L, Mosher D, Flanagan C, Keen KJ, Adams K, Mallinson M, Thorne C, Rahman P, Gladman DD, Inman RD. 2014 Update of the Canadian Rheumatology Association/spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis. Part I: principles of the management of spondyloarthritis in Canada. The Journal of Rheumatology. 42: 654-64. PMID 25684770 DOI: 10.3899/Jrheum.141000 |
0.377 |
|
| 2015 |
Rohekar S, Chan J, Tse SM, Haroon N, Chandran V, Bessette L, Mosher D, Flanagan C, Keen KJ, Adams K, Mallinson M, Thorne C, Rahman P, Gladman DD, Inman RD. 2014 Update of the Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Treatment Recommendations for the Management of Spondyloarthritis. Part II: Specific Management Recommendations. The Journal of Rheumatology. 42: 665-81. PMID 25684768 DOI: 10.3899/Jrheum.141001 |
0.38 |
|
| 2015 |
Haddad A, Thavaneswaran A, Ruiz-Arruza I, Pellett F, Chandran V, Cook RJ, Gladman DD. Minimal disease activity and anti-tumor necrosis factor therapy in psoriatic arthritis. Arthritis Care & Research. 67: 842-7. PMID 25469741 DOI: 10.1002/Acr.22529 |
0.487 |
|
| 2015 |
Eder L, Chandran V, Gladman DD. What have we learned about genetic susceptibility in psoriasis and psoriatic arthritis? Current Opinion in Rheumatology. 27: 91-8. PMID 25415529 DOI: 10.1097/Bor.0000000000000136 |
0.592 |
|
| 2015 |
Pollock RA, Abji F, Liang K, Chandran V, Pellett FJ, Virtanen C, Gladman DD. Gene expression differences between psoriasis patients with and without inflammatory arthritis. The Journal of Investigative Dermatology. 135: 620-3. PMID 25243786 DOI: 10.1038/Jid.2014.414 |
0.477 |
|
| 2015 |
Das S, Stuart PE, Ding J, Tejasvi T, Li Y, Tsoi LC, Chandran V, Fischer J, Helms C, Duffin KC, Voorhees JJ, Bowcock AM, Krueger GG, Lathrop GM, Nair RP, ... ... Gladman D, et al. Fine mapping of eight psoriasis susceptibility loci. European Journal of Human Genetics : Ejhg. 23: 844-53. PMID 25182136 DOI: 10.1038/Ejhg.2014.172 |
0.46 |
|
| 2015 |
Eder L, Thavaneswaran A, Chandran V, Cook R, Gladman DD. Factors explaining the discrepancy between physician and patient global assessment of joint and skin disease activity in psoriatic arthritis patients. Arthritis Care & Research. 67: 264-72. PMID 25047020 DOI: 10.1002/Acr.22401 |
0.673 |
|
| 2015 |
Eder L, Thavaneswaran A, Chandran V, Cook RJ, Gladman DD. Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis. Annals of the Rheumatic Diseases. 74: 813-7. PMID 24431392 DOI: 10.1136/Annrheumdis-2013-204448 |
0.638 |
|
| 2015 |
Tillett W, Eder L, Goel N, De Wit M, Ogdie A, Orbai AM, Campbell W, Fitzgerald O, McHugh NJ, Gladman DD, Strand V, Mease PJ. Review of the psoriatic arthritis working group at OMERACT 12: A report from the GRAPPA 2014 annual meeting Journal of Rheumatology. 42: 1048-1051. DOI: 10.3899/Jrheum.150131 |
0.526 |
|
| 2015 |
Pollock R, O'Rielly D, Dohey A, Codner D, Chandran V, Gladman D, Rahman P. THU0006 Validation of Differential Methylation in Maternally Versus Paternally Transmitted Psoriatic Disease Annals of the Rheumatic Diseases. 74: 195.1-195. DOI: 10.1136/Annrheumdis-2015-Eular.5891 |
0.56 |
|
| 2015 |
Maldonado-Ficco H, Gladman D. SAT0570 Joint Damage is Not Associated with Smoking Status in Patients with Psoriatic Arthritis Annals of the Rheumatic Diseases. 74: 867.1-867. DOI: 10.1136/Annrheumdis-2015-Eular.5334 |
0.39 |
|
| 2015 |
Nantes S, Urowitz M, Gladman D, Su J, Dhaliwal A, Touma Z. SAT0386 What is the Best Screening Test to Identify Lupus Patients with Cognitive Impairment in an Ambulatory Setting? Annals of the Rheumatic Diseases. 74: 799.1-799. DOI: 10.1136/Annrheumdis-2015-Eular.5021 |
0.347 |
|
| 2015 |
Gladman D, Mease P, Smolen J, Weinman J, Kalus S, Dorr A, Hojnik M, Nurwakagari P, Selenko-Gebauer N. SAT0566 Impact of Disease Management by Rheumatologists and Dermatologists on Patients' Attitude Toward Medication in Psoriatic Arthritis: Results from the Global Align Study Annals of the Rheumatic Diseases. 74: 865.2-866. DOI: 10.1136/Annrheumdis-2015-Eular.4179 |
0.354 |
|
| 2015 |
Smolen J, Gladman D, McNeil H, Weinman J, Kalus S, Dorr A, Hojnik M, Nurwakagari P, Selenko-Gebauer N. FRI0353 Association of Attitudes Toward Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs and Tumor Necrosis Factor Inhibitors and Treatment Adherence in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis: Results from the Global Align Study Annals of the Rheumatic Diseases. 74: 553.2-554. DOI: 10.1136/Annrheumdis-2015-Eular.4064 |
0.39 |
|
| 2015 |
Gladman D, Kavanaugh A, Adebajo A, Gomez-Reino J, Wollenhaupt J, Cutolo M, Schett G, Lespessailles E, McIlraith M, Hu C, Edwards C, Birbara C, Mease P. OP0169 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (104-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Results from Three Phase 3, Randomized, Controlled Trials Annals of the Rheumatic Diseases. 74: 133-134. DOI: 10.1136/Annrheumdis-2015-Eular.3594 |
0.327 |
|
| 2015 |
Kavanaugh A, Adebajo A, Gladman D, Gomez-Reino J, Hall S, Lespessailles E, Mease P, Schett G, Shah K, Hu C, Wollenhaupt J. THU0420 Long-Term (104-Week) Efficacy and Safety Profile of Apremilast, An Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results from a Phase III, Randomised, Controlled Trial and Open-Label Extension (Palace 1) Annals of the Rheumatic Diseases. 74: 350.2-351. DOI: 10.1136/Annrheumdis-2015-Eular.2907 |
0.387 |
|
| 2015 |
FitzGerald O, Fleischmann R, Hoepken B, Peterson L, Gladman D. THU0417 Improvements in Extra-Articular Manifestations of Psoriatic Arthritis Over 96 Weeks of Certolizumab Pegol Treatment Annals of the Rheumatic Diseases. 74: 349.1-349. DOI: 10.1136/Annrheumdis-2015-Eular.1847 |
0.318 |
|
| 2015 |
Kavanaugh A, Gladman D, Heijde Dvd, Purcaru O, Mease PJ. SAT0564 Clinical Responses in Joint and Skin Outcomes and Patient-Reported Outcomes are Associated with Increased Productivity in the Workplace and at Home in Psoriatic Arthritis Patients Treated with Certolizumab Pegol Annals of the Rheumatic Diseases. 74: 864-865. DOI: 10.1136/Annrheumdis-2015-Eular.1524 |
0.35 |
|
| 2015 |
Mease P, Kavanaugh A, Coates L, McInnes I, Hojnik M, Zhang Y, Anderson J, Dorr A, Gladman D. THU0431 The Prediction and Benefits of Minimal Disease Activity in Patients with Psoriatic Arthritis in the Adept Trial Annals of the Rheumatic Diseases. 74: 355.2-355. DOI: 10.1136/Annrheumdis-2015-Eular.1469 |
0.409 |
|
| 2015 |
Shoimer I, Kalia S, Gladman D, Pellett F, Mydlarski R. HLA associations in patients with pemphigus vulgaris: A Canadian perspective: 976 Journal of the American Academy of Dermatology. 72. DOI: 10.1016/J.Jaad.2015.02.134 |
0.369 |
|
| 2015 |
Eder L, Abji F, Rosen C, Chandran V, Gladman D. HLA-Class I genes are associated with a higher burden of atherosclerosis in patients with psoriatic disease Atherosclerosis. 241: e53. DOI: 10.1016/J.Atherosclerosis.2015.04.187 |
0.654 |
|
| 2014 |
Kavanaugh A, Gladman D, van dH, Purcaru O, Mease PJ. Sustained Improvements in Workplace and Household Productivity and Social Participation With Certolizumab Pegol Over 96 Weeks in Patients With Psoriatic Arthritis. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 17: A387-8. PMID 27200879 DOI: 10.1016/J.Jval.2014.08.2654 |
0.313 |
|
| 2014 |
Gladman D, Fleischmann R, Szegvari B, Peterson L, Mease PJ. Long-Term Maintenance of Improvements in Multiple Facets of Psoriatic Arthritis With Certolizumab Pegol: 96-Week Patient-Reported Outcome Results Of The Rapid-Psa Study. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 17: A386. PMID 27200875 DOI: 10.1016/J.Jval.2014.08.2646 |
0.357 |
|
| 2014 |
Haddad A, Thavaneswaran A, Abji F, Pellett F, Chandran V, Wither JE, Gladman DD. Immunoglobulin G subclass analysis in psoriatic arthritis. The Journal of Rheumatology. 41: 2421-4. PMID 25320220 DOI: 10.3899/Jrheum.131477 |
0.451 |
|
| 2014 |
Asiri A, Thavaneswaran A, Kalman-Lamb G, Chandran V, Gladman DD. The effectiveness of leflunomide in psoriatic arthritis. Clinical and Experimental Rheumatology. 32: 728-31. PMID 25151858 |
0.45 |
|
| 2014 |
Okada Y, Han B, Tsoi LC, Stuart PE, Ellinghaus E, Tejasvi T, Chandran V, Pellett F, Pollock R, Bowcock AM, Krueger GG, Weichenthal M, Voorhees JJ, Rahman P, Gregersen PK, ... ... Gladman DD, et al. Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes. American Journal of Human Genetics. 95: 162-72. PMID 25087609 DOI: 10.1016/J.Ajhg.2014.07.002 |
0.427 |
|
| 2014 |
Helliwell P, Coates L, Chandran V, Gladman D, de Wit M, FitzGerald O, Kavanaugh A, Strand V, Mease PJ, Boehncke WH, Langley RG, Lubrano E, Maccarone M, Schulze-Koops H, Miceli-Richard C, et al. Qualifying unmet needs and improving standards of care in psoriatic arthritis. Arthritis Care & Research. 66: 1759-66. PMID 25047391 DOI: 10.1002/Acr.22404 |
0.56 |
|
| 2014 |
Eder L, Gladman DD, Ibañez D, Urowitz MB. The correlation between carotid artery atherosclerosis and clinical ischemic heart disease in lupus patients. Lupus. 23: 1142-8. PMID 24876099 DOI: 10.1177/0961203314537696 |
0.552 |
|
| 2014 |
Gladman DD, Abufayyah M, Abuffayah M, Salonen D, Thavaneswaran A, Chandran V. Radiological characteristics of the calcaneal spurs in psoriatic arthritis. Clinical and Experimental Rheumatology. 32: 401-3. PMID 24850064 |
0.451 |
|
| 2014 |
Eder L, Thavaneswaran A, Chandran V, Cook R, Gladman DD. Increased burden of inflammation over time is associated with the extent of atherosclerotic plaques in patients with psoriatic arthritis. Annals of the Rheumatic Diseases. PMID 24827532 DOI: 10.1136/Annrheumdis-2014-205267 |
0.673 |
|
| 2014 |
Kavanaugh A, McInnes IB, Mease P, Krueger GG, Gladman D, van der Heijde D, Zhou Y, Lu J, Leu JH, Goldstein N, Beutler A. Clinical efficacy, radiographic and safety findings through 5 years of subcutaneous golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of a randomised, placebo-controlled trial (the GO-REVEAL study). Annals of the Rheumatic Diseases. 73: 1689-94. PMID 24748630 DOI: 10.1136/Annrheumdis-2013-204902 |
0.324 |
|
| 2014 |
Kennedy M, Papneja A, Thavaneswaran A, Chandran V, Gladman DD. Prevalence and predictors of reduced work productivity in patients with psoriatic arthritis. Clinical and Experimental Rheumatology. 32: 342-8. PMID 24708934 |
0.5 |
|
| 2014 |
Eder L, Gladman DD. Predictors for clinical outcome in psoriatic arthritis - what have we learned from cohort studies? Expert Review of Clinical Immunology. 10: 763-70. PMID 24702706 DOI: 10.1586/1744666X.2014.905741 |
0.555 |
|
| 2014 |
McDonough E, Ayearst R, Eder L, Chandran V, Rosen CF, Thavaneswaran A, Gladman DD. Depression and anxiety in psoriatic disease: prevalence and associated factors. The Journal of Rheumatology. 41: 887-96. PMID 24692521 DOI: 10.3899/Jrheum.130797 |
0.609 |
|
| 2014 |
Biagioni BJ, Gladman DD, Cook RJ, Eder L, Wakhlu A, Shen H, Chandran V. Reliability of radiographic scoring methods in axial psoriatic arthritis. Arthritis Care & Research. 66: 1417-22. PMID 24515627 DOI: 10.1002/Acr.22308 |
0.614 |
|
| 2014 |
Eder L, Jayakar J, Thavaneswaran A, Haddad A, Chandran V, Salonen D, Rosen CF, Gladman DD. Is the MAdrid Sonographic Enthesitis Index useful for differentiating psoriatic arthritis from psoriasis alone and healthy controls? The Journal of Rheumatology. 41: 466-72. PMID 24488414 DOI: 10.3899/Jrheum.130949 |
0.672 |
|
| 2014 |
Lertratanakul A, Wu P, Dyer A, Urowitz M, Gladman D, Fortin P, Bae SC, Gordon C, Clarke A, Bernatsky S, Hanly JG, Isenberg D, Rahman A, Merrill J, Wallace DJ, et al. 25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort. Arthritis Care & Research. 66: 1167-76. PMID 24470118 DOI: 10.1002/Acr.22291 |
0.313 |
|
| 2014 |
Gladman D, Fleischmann R, Coteur G, Woltering F, Mease PJ. Effect of certolizumab pegol on multiple facets of psoriatic arthritis as reported by patients: 24-week patient-reported outcome results of a phase III, multicenter study. Arthritis Care & Research. 66: 1085-92. PMID 24339179 DOI: 10.1002/Acr.22256 |
0.394 |
|
| 2014 |
Chandran V, Bull SB, Pellett FJ, Ayearst R, Pollock RA, Gladman DD. Killer-cell immunoglobulin-like receptor gene polymorphisms and susceptibility to psoriatic arthritis. Rheumatology (Oxford, England). 53: 233-9. PMID 24185760 DOI: 10.1093/Rheumatology/Ket296 |
0.444 |
|
| 2014 |
Eder L, Chandran V, Gladman DD. The Framingham Risk Score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease. Annals of the Rheumatic Diseases. 73: 1990-6. PMID 23887287 DOI: 10.1136/Annrheumdis-2013-203433 |
0.641 |
|
| 2014 |
Eder L, Thavaneswaran A, Chandran V, Gladman DD. Tumour necrosis factor α blockers are more effective than methotrexate in the inhibition of radiographic joint damage progression among patients with psoriatic arthritis. Annals of the Rheumatic Diseases. 73: 1007-11. PMID 23619157 DOI: 10.1136/Annrheumdis-2012-202959 |
0.675 |
|
| 2014 |
Mease P, Kavanaugh A, Gladman D, Adebajo A, Gomez-Reino J, Wollenhaupt J, Cutolo M, Schett G, Lespessailles E, Shah K, Hu C, Stevens R, Edwards C, Birbara C. SAT0408 Long-Term Safety and Tolerability of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of Three Phase 3, Randomized, Controlled Trials Annals of the Rheumatic Diseases. 73: 742.2-743. DOI: 10.1136/Annrheumdis-2014-Eular.5589 |
0.346 |
|
| 2014 |
O'Rielly D, Pollock R, Zhang Y, Al-Ghanim N, Yazdani R, Hamilton S, Bricknell R, Chandran V, Ardern R, Gladman D, Zhai G, Rahman P. AB0160 Epigenetic Studies in Maternally versus Paternally Transmitted Psoriatic Disease Annals of the Rheumatic Diseases. 73: 856.1-856. DOI: 10.1136/Annrheumdis-2014-Eular.3309 |
0.412 |
|
| 2014 |
Kavanaugh A, McInnes I, Mease P, Krueger G, Gladman D, Xu S, Tang L, Beneden KV. OP0080 Impact of Persistent Minimal Disease Activity on Long-Term Outcomes in Psoriatic Arthritis: Results from 5 Years of the Long Term Extension of A Randomized, Placebo-Controlled, Study Annals of the Rheumatic Diseases. 73: 92-92. DOI: 10.1136/Annrheumdis-2014-Eular.2254 |
0.328 |
|
| 2014 |
Kavanaugh A, Cutolo M, Mease P, Gladman D, Adebajo A, Gomez-Reino J, Wollenhaupt J, Schett G, Lespessailles E, Hu C, Stevens R, Edwards C, Birbara C. OP0078 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (52-WEEK) Improvement in Measures of Disease Activity in Patients with Psoriatic Arthritis: Results from 3 Phase 3, Randomized, Controlled Trials Annals of the Rheumatic Diseases. 73: 90.2-91. DOI: 10.1136/Annrheumdis-2014-Eular.1827 |
0.381 |
|
| 2014 |
Schett G, Mease P, Gladman D, Kavanaugh A, Adebajo A, Gomez-Reino J, Wollenhaupt J, Cutolo M, Lespessailles E, Hu C, Stevens R, Edwards C, Birbara C. AB0746 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, and the Impact of Baseline Weight and BMI on ACR20 and HAQ-DI Response: Pooled Results from 3 Phase 3, Randomized, Controlled Trials Annals of the Rheumatic Diseases. 73: 1050.2-1050. DOI: 10.1136/Annrheumdis-2014-Eular.1773 |
0.339 |
|
| 2014 |
Gladman DD, Chandran V. Management of psoriatic arthritis Rheumatology: Sixth Edition. 2: 1008-1013. DOI: 10.1016/B978-0-323-09138-1.00122-4 |
0.398 |
|
| 2013 |
Nikpour M, Gladman DD, Urowitz MB. Premature coronary heart disease in systemic lupus erythematosus: what risk factors do we understand? Lupus. 22: 1243-50. PMID 24097996 DOI: 10.1177/0961203313493031 |
0.309 |
|
| 2013 |
Eder L, Urowitz MB, Gladman DD. Damage in lupus patients--what have we learned so far? Lupus. 22: 1225-31. PMID 24097994 DOI: 10.1177/0961203313492872 |
0.592 |
|
| 2013 |
Mease PJ, Gladman DD, Papp KA, Khraishi MM, Thaçi D, Behrens F, Northington R, Fuiman J, Bananis E, Boggs R, Alvarez D. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. Journal of the American Academy of Dermatology. 69: 729-35. PMID 23981683 DOI: 10.1016/J.Jaad.2013.07.023 |
0.312 |
|
| 2013 |
Chandran V, Bull SB, Pellett FJ, Ayearst R, Rahman P, Gladman DD. Human leukocyte antigen alleles and susceptibility to psoriatic arthritis. Human Immunology. 74: 1333-8. PMID 23916976 DOI: 10.1016/J.Humimm.2013.07.014 |
0.403 |
|
| 2013 |
Mease PJ, Garg A, Gladman DD, Helliwell PS. Development of simple clinical criteria for the definition of inflammatory arthritis, enthesitis, dactylitis, and spondylitis: a report from the GRAPPA 2012 annual meeting. The Journal of Rheumatology. 40: 1442-5. PMID 23908542 DOI: 10.3899/jrheum.130459 |
0.313 |
|
| 2013 |
Chandran V, Gladman DD, Helliwell PS, Gudbjörnsson B. Arthritis mutilans: a report from the GRAPPA 2012 annual meeting. The Journal of Rheumatology. 40: 1419-22. PMID 23908536 DOI: 10.3899/Jrheum.130453 |
0.506 |
|
| 2013 |
Mease PJ, Boehncke WH, Gladman DD. Prologue: 2012 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The Journal of Rheumatology. 40: 1407-9. PMID 23908533 DOI: 10.3899/jrheum.130450 |
0.305 |
|
| 2013 |
Gladman DD, Ziouzina O, Thavaneswaran A, Chandran V. Dactylitis in psoriatic arthritis: prevalence and response to therapy in the biologic era. The Journal of Rheumatology. 40: 1357-9. PMID 23818708 DOI: 10.3899/Jrheum.130163 |
0.504 |
|
| 2013 |
Haddad A, Thavaneswaran A, Toloza S, Chandran V, Gladman DD. Diffuse idiopathic skeletal hyperostosis in psoriatic arthritis. The Journal of Rheumatology. 40: 1367-73. PMID 23772085 DOI: 10.3899/Jrheum.121433 |
0.538 |
|
| 2013 |
Husted JA, Thavaneswaran A, Chandran V, Gladman DD. Incremental effects of comorbidity on quality of life in patients with psoriatic arthritis. The Journal of Rheumatology. 40: 1349-56. PMID 23772076 DOI: 10.3899/Jrheum.121500 |
0.471 |
|
| 2013 |
Kavanaugh A, McInnes IB, Krueger GG, Gladman D, Beutler A, Gathany T, Mack M, Tandon N, Han C, Mease P. Patient-reported outcomes and the association with clinical response in patients with active psoriatic arthritis treated with golimumab: findings through 2 years of a phase III, multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Care & Research. 65: 1666-73. PMID 23666608 DOI: 10.1002/Acr.22044 |
0.389 |
|
| 2013 |
Chandran V, Shen H, Pollock RA, Pellett FJ, Carty A, Cook RJ, Gladman DD. Soluble biomarkers associated with response to treatment with tumor necrosis factor inhibitors in psoriatic arthritis. The Journal of Rheumatology. 40: 866-71. PMID 23637322 DOI: 10.3899/Jrheum.121162 |
0.488 |
|
| 2013 |
Pollock RA, Chandran V, Pellett FJ, Thavaneswaran A, Eder L, Barrett J, Rahman P, Farewell V, Gladman DD. The functional MICA-129 polymorphism is associated with skin but not joint manifestations of psoriatic disease independently of HLA-B and HLA-C. Tissue Antigens. 82: 43-7. PMID 23611695 DOI: 10.1111/Tan.12126 |
0.635 |
|
| 2013 |
Coates LC, FitzGerald O, Gladman DD, McHugh N, Mease P, Strand V, Helliwell PS. Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active disease. Arthritis and Rheumatism. 65: 1504-9. PMID 23529837 DOI: 10.1002/art.37939 |
0.346 |
|
| 2013 |
Eder L, Gladman DD. Psoriatic arthritis: phenotypic variance and nosology. Current Rheumatology Reports. 15: 316. PMID 23371481 DOI: 10.1007/S11926-013-0316-4 |
0.561 |
|
| 2013 |
Chaudhry SR, Thavaneswaran A, Chandran V, Gladman DD. Physician scores vs patient self-report of joint and skin manifestations in psoriatic arthritis. Rheumatology (Oxford, England). 52: 705-11. PMID 23267168 DOI: 10.1093/Rheumatology/Kes355 |
0.53 |
|
| 2013 |
Eder L, Jayakar J, Pollock R, Pellett F, Thavaneswaran A, Chandran V, Rosen CF, Gladman DD. Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity. Annals of the Rheumatic Diseases. 72: 1956-61. PMID 23243196 DOI: 10.1136/Annrheumdis-2012-202325 |
0.648 |
|
| 2013 |
Touma Z, Gladman DD, MacKinnon A, Carette S, Abu-Shakra M, Askanase A, Nived O, Hanly JG, Landolt-Marticorena C, Tam LS, Toloza S, Nikpour M, Riddell C, Steiman A, Eder L, et al. Development and assessment of users' satisfaction with the systemic lupus erythematosus disease activity index 2000 responder index-50 website. The Journal of Rheumatology. 40: 34-9. PMID 23118108 DOI: 10.3899/Jrheum.120754 |
0.472 |
|
| 2013 |
Eissa A, Cretu D, Soosaipillai A, Thavaneswaran A, Pellett F, Diamandis A, Cevikbas F, Steinhoff M, Diamandis EP, Gladman D, Chandran V. Serum kallikrein-8 correlates with skin activity, but not psoriatic arthritis, in patients with psoriatic disease. Clinical Chemistry and Laboratory Medicine. 51: 317-25. PMID 23096109 DOI: 10.1515/Cclm-2012-0251 |
0.588 |
|
| 2013 |
Wagner CL, Visvanathan S, Elashoff M, McInnes IB, Mease PJ, Krueger GG, Murphy FT, Papp K, Gomez-Reino JJ, Mack M, Beutler A, Gladman D, Kavanaugh A. Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab. Annals of the Rheumatic Diseases. 72: 83-8. PMID 22975755 DOI: 10.1136/Annrheumdis-2012-201697 |
0.39 |
|
| 2013 |
Eder L, Barzilai M, Peled N, Gladman DD, Zisman D. The use of ultrasound for the assessment of enthesitis in patients with spondyloarthritis. Clinical Radiology. 68: 219-23. PMID 22959850 DOI: 10.1016/J.Crad.2012.07.018 |
0.505 |
|
| 2013 |
Eder L, Jayakar J, Shanmugarajah S, Thavaneswaran A, Pereira D, Chandran V, Rosen CF, Gladman DD. The burden of carotid artery plaques is higher in patients with psoriatic arthritis compared with those with psoriasis alone. Annals of the Rheumatic Diseases. 72: 715-20. PMID 22736087 DOI: 10.1136/Annrheumdis-2012-201497 |
0.693 |
|
| 2013 |
Eder L, Thavaneswaran A, Chandran V, Gladman DD. Gender difference in disease expression, radiographic damage and disability among patients with psoriatic arthritis. Annals of the Rheumatic Diseases. 72: 578-82. PMID 22589379 DOI: 10.1136/Annrheumdis-2012-201357 |
0.628 |
|
| 2013 |
Kavanaugh A, Gladman D, van der Heijde D, Purcaru O, Mease P. Improvements In Productivity At Paid Work And Within Household, And Increased Participation In Daily Activities After 24 Weeks Of Certolizumab Pegol Treatment Of Patients With Psoriatic Arthritis: Results Of A Phase 3 Double Blind Randomized Placebo-Controlled Study Value in Health. 16: A228. DOI: 10.1136/Annrheumdis-2014-205198 |
0.342 |
|
| 2013 |
Touma Z, Thavaneswaran A, Chandran V, Gladman DD. SAT0308 Responsiveness of Patient Reported Outcomes to Biological Treatment in Psoriatic Arthritis Annals of the Rheumatic Diseases. 72: A688.1-A688. DOI: 10.1136/Annrheumdis-2013-Eular.2033 |
0.486 |
|
| 2013 |
Eder L, Thavaneswaran A, Chandran V, Cook R, Gladman DD. SAT0288 Male Gender is Associated with Accelerated Radiographic Progression in Axial Damage but not with Progression of Peripheral Damage Annals of the Rheumatic Diseases. 72: A681.1-A681. DOI: 10.1136/Annrheumdis-2013-Eular.2013 |
0.654 |
|
| 2013 |
Kavanaugh A, Gladman D, Heijde Dvd, Purcaru O, Mease PJ. SAT0276 Improvements in Productivity at Paid Work and Within Household, and Increased Participation in Daily Activities After 24 Weeks of Certolizumab Pegol in Patients with Psoriatic Arthritis: Results of Rapid-PSA Study Annals of the Rheumatic Diseases. 72. DOI: 10.1136/Annrheumdis-2013-Eular.2001 |
0.31 |
|
| 2013 |
Haddad A, Thavaneswaran A, Arruza IR, Chandran V, Cook R, Gladman D. SAT0273 The Characteristics and Predictors of Minimal Disease Activity in Patients with Psoriatic Arthritis on TNF Blockers Annals of the Rheumatic Diseases. 72. DOI: 10.1136/Annrheumdis-2013-Eular.1998 |
0.617 |
|
| 2013 |
Gladman D, Fleischmann R, Coteur G, Woltering F, Mease PJ. SAT0260 Effect of Certolizumab Pegol on the Multiple Facets of Psoriatic Arthritis as Reported by Patients with and without Prior Anti-Tnf Exposure: 24-Week Patient-Reported Outcome Results of Rapid-PSA Study Annals of the Rheumatic Diseases. 72: A670.1-A670. DOI: 10.1136/Annrheumdis-2013-Eular.1985 |
0.383 |
|
| 2013 |
Fortin P, Aghdassi E, Ma D, Eder L, Morrison S, Frattasi M, Su J, Gladman D, Lonn E, Harvey P. AB0704 Red blood cell but not plasma phospholipids profile may be associated with the presence of carotid plaques in women with systemic lupus erythematosus Annals of the Rheumatic Diseases. 71: 678.18-678. DOI: 10.1136/Annrheumdis-2012-Eular.704 |
0.479 |
|
| 2013 |
Coates L, Fitzgerald O, Gladman D, McHugh N, Mease P, Strand V, Helliwell P. SAT0305 MDA criteria for PSA show good correlation with physician and patient opinions and with proposed composite measures Annals of the Rheumatic Diseases. 71: 575.2-575. DOI: 10.1136/Annrheumdis-2012-Eular.3252 |
0.457 |
|
| 2013 |
Coates L, Fitzgerald O, Gladman D, McHugh N, Mease P, Strand V, Helliwell P. SAT0291 Reduced joint counts misclassify PSA patients with oligoarthritis and miss significant active disease Annals of the Rheumatic Diseases. 71: 570.2-570. DOI: 10.1136/ANNRHEUMDIS-2012-EULAR.3238 |
0.328 |
|
| 2013 |
Kavanaugh A, Gladman D, van der Heijde D, Purcaru O, Mease P. Sustained Improvements in Productivity at Paid Work and Within Household, and Increased Participation in Daily Activities Over Time with Certolizumab Pegol in Patients with Psoriatic Arthritis: 48-Week Results from the Rapid-PsA Study Value in Health. 16: A570. DOI: 10.1016/J.Jval.2013.08.1531 |
0.362 |
|
| 2013 |
Gladman D, Fleischmann R, Coteur G, Woltering F, Mease P. Effect Of Certolizumab Pegol On The Multiple Facets Of Psoriatic Arthritis As Reported By Patients: 24-Week Patient Reported Outcome Results Of A Phase 3 Double Blind Randomized Placebo-Controlled Study Value in Health. 16: A227. DOI: 10.1016/J.Jval.2013.03.1151 |
0.362 |
|
| 2013 |
Eder L, Gladman DD. Outcome Measures in Psoriatic Disease Current Dermatology Reports. 2: 164-171. DOI: 10.1007/S13671-013-0050-1 |
0.572 |
|
| 2012 |
Tsoi LC, Spain SL, Knight J, Ellinghaus E, Stuart PE, Capon F, Ding J, Li Y, Tejasvi T, Gudjonsson JE, Kang HM, Allen MH, McManus R, Novelli G, Samuelsson L, ... ... Gladman DD, et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nature Genetics. 44: 1341-8. PMID 23143594 DOI: 10.1038/Ng.2467 |
0.415 |
|
| 2012 |
Gladman DD. Biomarkers for comorbidities in psoriasis: a report from the GRAPPA 2011 annual meeting. The Journal of Rheumatology. 39: 2193-5. PMID 23118285 DOI: 10.3899/jrheum.120821 |
0.337 |
|
| 2012 |
Gladman DD, Chandran V, Thavaneswaran A, Zummer M. Psoriatic arthritis in Canadian clinical practice: the PsA assessment in rheumatology. The Journal of Rheumatology. 39: 1850-3. PMID 22859361 DOI: 10.3899/Jrheum.120282 |
0.569 |
|
| 2012 |
Eder L, Chandran V, Pellett F, Shanmugarajah S, Rosen CF, Bull SB, Gladman DD. Differential human leucocyte allele association between psoriasis and psoriatic arthritis: a family-based association study. Annals of the Rheumatic Diseases. 71: 1361-5. PMID 22586163 DOI: 10.1136/Annrheumdis-2012-201308 |
0.621 |
|
| 2012 |
Manzi S, Sánchez-Guerrero J, Merrill JT, Furie R, Gladman D, Navarra SV, Ginzler EM, D'Cruz DP, Doria A, Cooper S, Zhong ZJ, Hough D, Freimuth W, Petri MA. Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials. Annals of the Rheumatic Diseases. 71: 1833-8. PMID 22550315 DOI: 10.1136/Annrheumdis-2011-200831 |
0.32 |
|
| 2012 |
Jordan CT, Cao L, Roberson ED, Duan S, Helms CA, Nair RP, Duffin KC, Stuart PE, Goldgar D, Hayashi G, Olfson EH, Feng BJ, Pullinger CR, Kane JP, Wise CA, ... ... Gladman D, et al. Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis. American Journal of Human Genetics. 90: 796-808. PMID 22521419 DOI: 10.1016/J.Ajhg.2012.03.013 |
0.474 |
|
| 2012 |
Touma Z, Thavaneswaran A, Chandran V, Gladman DD. Does the change in season affect disease activity in patients with psoriatic arthritis? Annals of the Rheumatic Diseases. 71: 1370-3. PMID 22504562 DOI: 10.1136/Annrheumdis-2011-201208 |
0.538 |
|
| 2012 |
Eder L, Thavaneswaran A, Pereira D, Sussman G, Gladman DD. Prevalence of monoclonal gammopathy among patients with psoriatic arthritis. The Journal of Rheumatology. 39: 564-7. PMID 22247355 DOI: 10.3899/Jrheum.111054 |
0.575 |
|
| 2012 |
Rosen CF, Mussani F, Chandran V, Eder L, Thavaneswaran A, Gladman DD. Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone. Rheumatology (Oxford, England). 51: 571-6. PMID 22157469 DOI: 10.1093/Rheumatology/Ker365 |
0.654 |
|
| 2012 |
Tejasvi T, Stuart PE, Chandran V, Voorhees JJ, Gladman DD, Rahman P, Elder JT, Nair RP. TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis. The Journal of Investigative Dermatology. 132: 593-600. PMID 22113471 DOI: 10.1038/Jid.2011.376 |
0.457 |
|
| 2012 |
Eder L, Shanmugarajah S, Thavaneswaran A, Chandran V, Rosen CF, Cook RJ, Gladman DD. The association between smoking and the development of psoriatic arthritis among psoriasis patients. Annals of the Rheumatic Diseases. 71: 219-24. PMID 21953342 DOI: 10.1136/Ard.2010.147793 |
0.608 |
|
| 2012 |
Eder L, Chandran V, Pellet F, Shanmugarajah S, Rosen CF, Bull SB, Gladman DD. Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis. Annals of the Rheumatic Diseases. 71: 50-5. PMID 21900282 DOI: 10.1136/Ard.2011.155044 |
0.61 |
|
| 2012 |
Eder L, Chandran V, Gladman DD. Dr. Eder, et al, reply Journal of Rheumatology. 39: 186. DOI: 10.3899/Jrheum.110828 |
0.532 |
|
| 2012 |
Eder L, Chandran V, Gladman DD. Gender-related differences in patients with psoriatic arthritis International Journal of Clinical Rheumatology. 7: 641-649. DOI: 10.2217/Ijr.12.63 |
0.621 |
|
| 2012 |
Touma Z, Gladman D, Urowitz M. Development validation and reliability of the Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 Arthritis Research & Therapy. 14. DOI: 10.1186/Ar3989 |
0.33 |
|
| 2012 |
Clarke A, Bernatsky S, Costenbader K, Urowitz M, Gladman D, Fortin P, Petri M, Manzi S, Isenberg D, Rahman A, Wallace D, Gordon C, Peschken C, Dooley M, Ginzler E, et al. Lymphoma risk in systemic lupus: effects of treatment versus disease activity Arthritis Research & Therapy. 14: 1-28. DOI: 10.1186/Ar3950 |
0.322 |
|
| 2012 |
Gladman DD, Thavaneswaran A, Chandran V. Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease? (Annals of the Rheumatic Diseases (2011) 70, (2152-2154)) Annals of the Rheumatic Diseases. 71: 1592. DOI: 10.1136/ard.2011.150938corr1 |
0.516 |
|
| 2011 |
Touma Z, Eder L, Zisman D, Feld J, Chandran V, Rosen CF, Shen H, Cook RJ, Gladman DD. Seasonal variation in vitamin D levels in psoriatic arthritis patients from different latitudes and its association with clinical outcomes. Arthritis Care & Research. 63: 1440-7. PMID 22121512 DOI: 10.1002/Acr.20530 |
0.609 |
|
| 2011 |
MacKenzie H, Thavaneswaran A, Chandran V, Gladman DD. Patient-reported outcome in psoriatic arthritis: a comparison of Web-based versus paper-completed questionnaires. The Journal of Rheumatology. 38: 2619-24. PMID 22045844 DOI: 10.3899/Jrheum.110165 |
0.51 |
|
| 2011 |
Gladman DD, Thavaneswaran A, Chandran V, Cook RJ. Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease? Annals of the Rheumatic Diseases. 70: 2152-4. PMID 21914627 DOI: 10.1136/Ard.2011.150938 |
0.537 |
|
| 2011 |
Husted JA, Thavaneswaran A, Chandran V, Eder L, Rosen CF, Cook RJ, Gladman DD. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. Arthritis Care & Research. 63: 1729-35. PMID 21905258 DOI: 10.1002/Acr.20627 |
0.695 |
|
| 2011 |
Hanly JG, Urowitz MB, Su L, Bae SC, Gordon C, Clarke A, Bernatsky S, Vasudevan A, Isenberg D, Rahman A, Wallace DJ, Fortin PR, Gladman D, Romero-Diaz J, Romero-Dirz J, et al. Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 70: 1726-32. PMID 21893582 DOI: 10.1136/Ard.2010.148502 |
0.344 |
|
| 2011 |
Pollock RA, Pellett FJ, Chandran V, Gladman DD. Expression patterns of natural killer receptor genes in inflamed joints and peripheral blood of patients with psoriatic arthritis. Tissue Antigens. 78: 345-7. PMID 21883096 DOI: 10.1111/J.1399-0039.2011.01764.X |
0.437 |
|
| 2011 |
Evans DM, Spencer CC, Pointon JJ, Su Z, Harvey D, Kochan G, Oppermann U, Opperman U, Dilthey A, Pirinen M, Stone MA, Appleton L, Moutsianas L, Moutsianis L, Leslie S, ... ... Gladman D, et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nature Genetics. 43: 761-7. PMID 21743469 DOI: 10.1038/Ng.873 |
0.306 |
|
| 2011 |
Eder L, Chandran V, Pellett F, Pollock R, Shanmugarajah S, Rosen CF, Rahman P, Gladman DD. IL13 gene polymorphism is a marker for psoriatic arthritis among psoriasis patients. Annals of the Rheumatic Diseases. 70: 1594-8. PMID 21613309 DOI: 10.1136/Ard.2010.147421 |
0.597 |
|
| 2011 |
Eder L, Law T, Chandran V, Shanmugarajah S, Shen H, Rosen CF, Cook RJ, Gladman DD. Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care & Research. 63: 1091-7. PMID 21560259 DOI: 10.1002/Acr.20496 |
0.624 |
|
| 2011 |
Gladman DD, Chandran V. Review of clinical registries of psoriatic arthritis: lessons learned?: value for the future? Current Rheumatology Reports. 13: 346-52. PMID 21494786 DOI: 10.1007/S11926-011-0182-X |
0.539 |
|
| 2011 |
Pollock R, Chandran V, Barrett J, Eder L, Pellett F, Yao C, Lino M, Shanmugarajah S, Farewell VT, Gladman DD. Differential major histocompatibility complex class I chain-related A allele associations with skin and joint manifestations of psoriatic disease. Tissue Antigens. 77: 554-61. PMID 21457151 DOI: 10.1111/J.1399-0039.2011.01670.X |
0.647 |
|
| 2011 |
Eder L, Chandran V, Shen H, Cook RJ, Shanmugarajah S, Rosen CF, Gladman DD. Incidence of arthritis in a prospective cohort of psoriasis patients. Arthritis Care & Research. 63: 619-22. PMID 21452273 DOI: 10.1002/Acr.20401 |
0.677 |
|
| 2011 |
Boehncke WH, Gladman DD, Chandran V. Cardiovascular comorbidities in psoriasis and psoriatic arthritis: pathogenesis, consequences for patient management, and future research agenda: a report from the GRAPPA 2009 annual meeting. The Journal of Rheumatology. 38: 567-71. PMID 21362790 DOI: 10.3899/Jrheum.101124 |
0.55 |
|
| 2011 |
Chandran V, Gladman DD. Toronto Psoriatic Arthritis Screening (ToPAS) questionnaire: a report from the GRAPPA 2009 annual meeting. The Journal of Rheumatology. 38: 546-7. PMID 21362783 DOI: 10.3899/Jrheum.101117 |
0.442 |
|
| 2011 |
Ippolito A, Wallace DJ, Gladman D, Fortin PR, Urowitz M, Werth V, Costner M, Gordon C, Alarcón GS, Ramsey-Goldman R, Maddison P, Clarke A, Bernatsky S, Manzi S, Bae SC, et al. Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity. Lupus. 20: 250-5. PMID 21362750 DOI: 10.1177/0961203310385738 |
0.322 |
|
| 2011 |
Eder L, Chandran V, Gladman DD. Repair of radiographic joint damage following treatment with etanercept in psoriatic arthritis is demonstrable by 3 radiographic methods. The Journal of Rheumatology. 38: 1066-70. PMID 21324963 DOI: 10.3899/Jrheum.100919 |
0.628 |
|
| 2011 |
Touma Z, Urowitz MB, Fortin PR, Landolt C, Toloza SM, Riddell C, Chandran V, Eder L, Ghanem A, Ziouzina O, Taghavi-Zadeh S, Ibañez D, Gladman DD. Systemic lupus erythematosus disease activity index 2000 responder index-50: a reliable index for measuring improvement in disease activity. The Journal of Rheumatology. 38: 868-73. PMID 21324961 DOI: 10.3899/Jrheum.101080 |
0.644 |
|
| 2011 |
Mease P, Genovese MC, Gladstein G, Kivitz AJ, Ritchlin C, Tak PP, Wollenhaupt J, Bahary O, Becker J, Kelly S, Sigal L, Teng J, Gladman D. Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial. Arthritis & Rheumatism. 63: 939-948. PMID 21128258 DOI: 10.1002/Art.30176 |
0.337 |
|
| 2011 |
Nikpour M, Urowitz MB, Ibañez D, Gladman DD. Relationship between cardiac symptoms, myocardial perfusion defects and coronary angiography findings in systemic lupus erythematosus. Lupus. 20: 299-304. PMID 21078763 DOI: 10.1177/0961203310381512 |
0.312 |
|
| 2011 |
Cresswell L, Chandran V, Farewell VT, Gladman DD. Inflammation in an individual joint predicts damage to that joint in psoriatic arthritis. Annals of the Rheumatic Diseases. 70: 305-8. PMID 20980703 DOI: 10.1136/Ard.2010.135087 |
0.507 |
|
| 2011 |
Budarf ML, Goyette P, Boucher G, Lian J, Graham RR, Claudio JO, Hudson T, Gladman D, Clarke AE, Pope JE, Peschken C, Smith CD, Hanly J, Rich E, Boire G, et al. A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles. Genes and Immunity. 12: 51-8. PMID 20962850 DOI: 10.1038/Gene.2010.47 |
0.341 |
|
| 2011 |
Gladman DD, Chandran V. Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program. Rheumatology (Oxford, England). 50: 25-31. PMID 20693260 DOI: 10.1093/Rheumatology/Keq262 |
0.506 |
|
| 2011 |
Evans DM, Reveille JD, Brown M, Chandran V, Gladman DD, Martin TM, McGovern D, Wordsworth P, Inman RD. The genetic basis of spondyloarthritis: SPARTAN/IGAS 2009 (Journal of Rheumatology (2010) 37 (2626-2631)) Journal of Rheumatology. 38: 788. DOI: 10.3899/Jrheum.100892C1 |
0.355 |
|
| 2011 |
Gladman DD, Chandran V. Standardizing the monitoring of outcome measures: Imaging in psoriatic arthritis International Journal of Clinical Rheumatology. 6: 77-86. DOI: 10.2217/Ijr.10.103 |
0.499 |
|
| 2011 |
Kavanaugh A, McInnes I, Krueger G, Gladman D, Beutler A, Gathany T, Mudivarthy S, Mack M, Tandon N, Han C, Mease P. PMS66 EARLY AND SUSTAINED REMISSION ASSOCIATED WITH NORMALIZED PHYSICAL FUNCTION AND HEALTH-RELATED QUALITY OF LIFE AND SIGNIFICANTLY IMPROVED PRODUCTIVITY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS TREATED WITH GOLIMUMAB: TWO YEAR DATA FROM THE PHASE III GO-REVEAL CLINICAL TRIAL Value in Health. 14: A135. DOI: 10.1016/J.Jval.2011.02.749 |
0.322 |
|
| 2011 |
Venner A, Ibanez D, Cheung J, Wong S, Grossi L, Gladman D, Urowitz M, MacKinnon A, Blasutig I, Yip P. The performance of three anti-dsDNA immunoassays and their correlation with disease activity in systemic lupus erythematosus patients Clinical Biochemistry. 44: 1184. DOI: 10.1016/J.Clinbiochem.2011.06.068 |
0.377 |
|
| 2010 |
Danoy P, Pryce K, Hadler J, Bradbury LA, Farrar C, Pointon J, Ward M, Weisman M, Reveille JD, Wordsworth BP, Stone MA, Maksymowych WP, Rahman P, ... Gladman D, et al. Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease. Plos Genetics. 6: e1001195. PMID 21152001 DOI: 10.1371/Journal.Pgen.1001195 |
0.327 |
|
| 2010 |
Evans DM, Reveille JD, Brown MA, Chandran V, Gladman DD, Martin TM, McGovern D, Wordsworth P, Inman RD. The genetic basis of spondyloarthritis: SPARTAN/IGAS 2009. The Journal of Rheumatology. 37: 2626-31. PMID 21123336 DOI: 10.3899/Jrheum.100892 |
0.418 |
|
| 2010 |
Weisman M, Learch TJ, Baraliakos X, Chandran V, Gladman DD, Raychaudhuri SP, Xu H, Collantes-Estévez E, Vázquez-Mellado J, Mease PJ, Sieper J, Deodhar AA, Colbert RA, Clegg DO. Current controversies in spondyloarthritis: SPARTAN. The Journal of Rheumatology. 37: 2617-23. PMID 21123334 DOI: 10.3899/Jrheum.100890 |
0.418 |
|
| 2010 |
Garg A, Gladman D. Recognizing psoriatic arthritis in the dermatology clinic Journal of the American Academy of Dermatology. 63: 733-748. PMID 20950737 DOI: 10.1016/J.Jaad.2010.02.061 |
0.46 |
|
| 2010 |
Eder L, Chandran V, Shen H, Cook RJ, Gladman DD. Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis? Annals of the Rheumatic Diseases. 69: 2160-4. PMID 20627946 DOI: 10.1136/Ard.2010.129726 |
0.653 |
|
| 2010 |
Chandran V, Siannis F, Rahman P, Pellett FJ, Farewell VT, Gladman DD. Folate pathway enzyme gene polymorphisms and the efficacy and toxicity of methotrexate in psoriatic arthritis. The Journal of Rheumatology. 37: 1508-12. PMID 20472929 DOI: 10.3899/Jrheum.091311 |
0.458 |
|
| 2010 |
Chandran V, Gladman DD. Update on biomarkers in psoriatic arthritis. Current Rheumatology Reports. 12: 288-94. PMID 20437120 DOI: 10.1007/S11926-010-0107-0 |
0.517 |
|
| 2010 |
Chandran V, Cook RJ, Edwin J, Shen H, Pellett FJ, Shanmugarajah S, Rosen CF, Gladman DD. Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis. Rheumatology (Oxford, England). 49: 1399-405. PMID 20421218 DOI: 10.1093/Rheumatology/Keq105 |
0.508 |
|
| 2010 |
Eder L, Chandran V, Ueng J, Bhella S, Lee KA, Rahman P, Pope A, Cook RJ, Gladman DD. Predictors of response to intra-articular steroid injection in psoriatic arthritis. Rheumatology (Oxford, England). 49: 1367-73. PMID 20388640 DOI: 10.1093/Rheumatology/Keq102 |
0.641 |
|
| 2010 |
Eder L, Chandran V, Schentag CT, Shen H, Cook RJ, Gladman DD. Time and predictors of response to tumour necrosis factor-alpha blockers in psoriatic arthritis: an analysis of a longitudinal observational cohort. Rheumatology (Oxford, England). 49: 1361-6. PMID 20385615 DOI: 10.1093/Rheumatology/Keq091 |
0.634 |
|
| 2010 |
Chandran V, Tolusso DC, Cook RJ, Gladman DD. Risk factors for axial inflammatory arthritis in patients with psoriatic arthritis. The Journal of Rheumatology. 37: 809-15. PMID 20231209 DOI: 10.3899/Jrheum.091059 |
0.537 |
|
| 2010 |
Coates LC, Cook R, Lee KA, Chandran V, Gladman DD. Frequency, predictors, and prognosis of sustained minimal disease activity in an observational psoriatic arthritis cohort. Arthritis Care & Research. 62: 970-6. PMID 20191569 DOI: 10.1002/Acr.20162 |
0.509 |
|
| 2010 |
Aghdassi E, Morrison S, Landolt-Marticorena C, Su J, Pineau CA, Gladman D, Urowitz M, Pope J, Peschken C, Dacosta D, Wither J, Fortin PR. The use of micronutrient supplements is not associated with better quality of life and disease activity in Canadian patients with systemic lupus erythematosus. The Journal of Rheumatology. 37: 87-90. PMID 19955051 DOI: 10.3899/Jrheum.090761 |
0.343 |
|
| 2010 |
Eder L, Sadek M, McDonald-Blumer H, Gladman DD. Aortitis and spondyloarthritis--an unusual presentation: case report and review of the literature. Seminars in Arthritis and Rheumatism. 39: 510-4. PMID 19217648 DOI: 10.1016/J.Semarthrit.2008.11.004 |
0.458 |
|
| 2010 |
Wig S, Bischoff P, Holt M, Collins S, Goodfellow R, Martin J, Rhys-Dillon C, Lyle S, Phillips JR, Mease PJ, Perdok R, Kary S, Kupper H, Humphreys E, Amos N, ... ... Gladman D, et al. Spondyloarthropathies (Including Psoriatic Arthritis) [40–69] 40. Eagle's Syndrome: An Unusual Association with Sero-Negative Arthropathy Rheumatology. 49. DOI: 10.1093/Rheumatology/Keq716 |
0.304 |
|
| 2010 |
Jadon DR, Cavill C, Waldron N, Barton A, Korendowych E, McHugh NJ, Coates LC, Helliwell PS, Heijde Dvd, Emery P, Patra K, Lavie F, Skerrett J, Weide Ivd, Barlow J, ... ... Gladman D, et al. Concurrent Oral 6 – Spondylarthropathies [OP40–OP47]OP40. Association of IL23R and IL12B Polymorphisms with Psoriatic Arthritis Rheumatology. 49. DOI: 10.1093/Rheumatology/Keq706 |
0.31 |
|
| 2009 |
Chandran V, Barrett J, Schentag CT, Farewell VT, Gladman DD. Axial psoriatic arthritis: update on a longterm prospective study. The Journal of Rheumatology. 36: 2744-50. PMID 19884276 DOI: 10.3899/Jrheum.090412 |
0.484 |
|
| 2009 |
Eder L, Chandran V, Gladman DD. From ankylosis to pencil-in-cup deformity in psoriatic arthritis: A case report Clinical and Experimental Rheumatology. 27: 661-663. PMID 19772803 |
0.633 |
|
| 2009 |
Nikpour M, Gladman DD, Ibañez D, Urowitz MB. Variability and correlates of high sensitivity C-reactive protein in systemic lupus erythematosus. Lupus. 18: 966-73. PMID 19762397 DOI: 10.1177/0961203309105130 |
0.408 |
|
| 2009 |
Chandran V, Gottlieb A, Cook RJ, Duffin KC, Garg A, Helliwell P, Kavanaugh A, Krueger GG, Langley RG, Lynde C, McHugh N, Mease P, Olivieri I, Rahman P, Rosen CF, ... ... Gladman DD, et al. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthritis and Rheumatism. 61: 1235-42. PMID 19714610 DOI: 10.1002/Art.24562 |
0.527 |
|
| 2009 |
Kavanaugh A, McInnes I, Mease P, Krueger GG, Gladman D, Gomez-Reino J, Papp K, Zrubek J, Mudivarthy S, Mack M, Visvanathan S, Beutler A. Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study. Arthritis & Rheumatism. 60: 976-986. PMID 19333944 DOI: 10.1002/Art.24403 |
0.386 |
|
| 2009 |
Hochman J, Urowitz MB, Ibañz D, Gladman DD. Hormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular disease Lupus. 18: 313-317. PMID 19276299 DOI: 10.1177/0961203308097475 |
0.353 |
|
| 2009 |
Toloza S, Pellett F, Chandran V, Ibanez D, Urowitz M, Gladman D. Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus. Lupus. 17: 793-8. PMID 18755860 DOI: 10.1177/0961203308089443 |
0.517 |
|
| 2009 |
Chandran V, Schentag CT, Brockbank JE, Pellett FJ, Shanmugarajah S, Toloza SM, Rahman P, Gladman DD. Familial aggregation of psoriatic arthritis. Annals of the Rheumatic Diseases. 68: 664-7. PMID 18524791 DOI: 10.1136/Ard.2008.089367 |
0.503 |
|
| 2009 |
Gladman DD, Schentag CT, Tom BD, Chandran V, Brockbank J, Rosen C, Farewell VT. Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS). Annals of the Rheumatic Diseases. 68: 497-501. PMID 18445625 DOI: 10.1136/Ard.2008.089441 |
0.413 |
|
| 2009 |
Pollock RA, Pellett FJ, Chandran V, Gladman D. 240-P: Killer cell immunoglobulin-like receptor gene expression in inflamed joints of patients with psoriatic arthritis (PsA) Human Immunology. 70: S133. DOI: 10.1016/J.Humimm.2009.09.273 |
0.528 |
|
| 2009 |
Pellett F, Chandran V, Rahman P, Gladman D. 154-P: Activating KIRs in siblings of patients with psoriatic arthritis Human Immunology. 70: S88. DOI: 10.1016/J.Humimm.2009.09.187 |
0.555 |
|
| 2008 |
Chandran V, Schentag CT, Gladman DD. Sensitivity and specificity of the CASPAR criteria for psoriatic arthritis in a family medicine clinic setting. The Journal of Rheumatology. 35: 2069-70; author repl. PMID 18843760 |
0.411 |
|
| 2008 |
Duffin KC, Chandran V, Gladman DD, Krueger GG, Elder JT, Rahman P. Genetics of psoriasis and psoriatic arthritis: update and future direction. The Journal of Rheumatology. 35: 1449-53. PMID 18609743 |
0.485 |
|
| 2008 |
Rahman P, Snelgrove T, Peddle L, Siannis F, Farewell V, Schentag C, Gladman D. A variant of the IL4 I50V single-nucleotide polymorphism is associated with erosive joint disease in psoriatic arthritis Arthritis and Rheumatism. 58: 2207-2208. PMID 18576348 DOI: 10.1002/Art.23558 |
0.331 |
|
| 2008 |
Hanly JG, Urowitz MB, Su L, Sanchez-Guerrero J, Bae SC, Gordon C, Wallace DJ, Isenberg D, Alarcón GS, Merrill JT, Clarke A, Bernatsky S, Dooley MA, Fortin PR, Gladman D, et al. Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study. Arthritis and Rheumatism. 59: 721-9. PMID 18438902 DOI: 10.1002/Art.23566 |
0.306 |
|
| 2008 |
Kimball AB, Gladman D, Gelfand JM, Gordon KB, Horn EJ, Korman NJ, Korver G, Krueger GG, Strober BE, Lebwohl MG. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening Journal of the American Academy of Dermatology. 58: 1031-1042. PMID 18313171 DOI: 10.1016/J.Jaad.2008.01.006 |
0.33 |
|
| 2008 |
Hanly JG, Urowitz MB, Siannis F, Farewell V, Gordon C, Bae SC, Isenberg D, Dooley MA, Clarke A, Bernatsky S, Gladman D, Fortin PR, Manzi S, Steinsson K, Bruce IN, et al. Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis and Rheumatism. 58: 843-53. PMID 18311802 DOI: 10.1002/Art.23218 |
0.316 |
|
| 2008 |
Urowitz MB, Gladman D, Ibañez D, Fortin P, Sanchez-Guerrero J, Bae S, Clarke A, Bernatsky S, Gordon C, Hanly J, Wallace D, Isenberg D, Ginzler E, Merrill J, Alarcón GS, et al. Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis and Rheumatism. 59: 176-80. PMID 18240193 DOI: 10.1002/Art.23353 |
0.341 |
|
| 2008 |
Chandran V, Schentag CT, Gladman DD. Reappraisal of the effectiveness of methotrexate in psoriatic arthritis: results from a longitudinal observational cohort. The Journal of Rheumatology. 35: 469-71. PMID 18085735 |
0.533 |
|
| 2008 |
Lebwohl M, Bagel J, Gelfand JM, Gladman D, Gordon KB, Hsu S, Kalb RE, Kimball AB, Korman NJ, Krueger GG, Mease P, Morison WL, Paller A, Pariser DM, Ritchlin C, et al. From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis. Journal of the American Academy of Dermatology. 58: 94-105. PMID 17980456 DOI: 10.1016/J.Jaad.2007.08.030 |
0.335 |
|
| 2008 |
Gladman DD. Psoriatic arthritis A. clinical features Primer On the Rheumatic Diseases: Thirteenth Edition. 170-177. DOI: 10.1007/978-0-387-68566-3_8 |
0.323 |
|
| 2007 |
Chandran V, O'Shea FD, Schentag CT, Inman RD, Gladman DD. Relationship between spinal mobility and radiographic damage in ankylosing spondylitis and psoriatic spondylitis: a comparative analysis. The Journal of Rheumatology. 34: 2463-5. PMID 18050375 |
0.427 |
|
| 2007 |
Chandran V, Schentag CT, Gladman DD. Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis and Rheumatism. 57: 1560-3. PMID 18050230 DOI: 10.1002/Art.23104 |
0.462 |
|
| 2007 |
Chandran V, Pellett F, Gladman DD. Killer cell immunoglobulin-like receptor gene's repertoire in rheumatoid arthritis [6] Scandinavian Journal of Rheumatology. 36: 409. PMID 17963178 DOI: 10.1080/03009740701406601 |
0.411 |
|
| 2007 |
Urowitz MB, Gladman D, Ibañez D, Fortin P, Sanchez-Guerrero J, Bae S, Clarke A, Bernatsky S, Gordon C, Hanly J, Wallace D, Isenberg D, Ginzler E, Merrill J, Alarcon G, et al. Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort. Lupus. 16: 731-5. PMID 17728367 DOI: 10.1177/0961203307081113 |
0.406 |
|
| 2007 |
Ali YM, Urowitz MB, Ibanez D, Gladman DD. Monoclonal gammopathy in systemic lupus erythematosus. Lupus. 16: 426-9. PMID 17664233 DOI: 10.1177/0961203307079045 |
0.309 |
|
| 2007 |
Gladman DD, Inman RD, Cook RJ, Maksymowych WP, Braun J, Davis JC, Landewé RB, Mease P, Brandt J, Vargas RB, Chandran V, Helliwell P, Kavanaugh A, O'Shea FD, Khan MA, et al. International spondyloarthritis interobserver reliability exercise--the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis. The Journal of Rheumatology. 34: 1740-5. PMID 17659754 |
0.532 |
|
| 2007 |
Gladman DD, Inman RD, Cook RJ, van der Heijde D, Landewé RB, Braun J, Davis JC, Mease P, Brandt J, Vargas RB, Chandran V, Helliwell P, Kavanaugh A, O'Shea FD, Khan MA, et al. International spondyloarthritis interobserver reliability exercise--the INSPIRE study: I. Assessment of spinal measures. The Journal of Rheumatology. 34: 1733-9. PMID 17611985 |
0.494 |
|
| 2007 |
Gladman DD, Mease PJ, Healy P, Helliwell PS, Fitzgerald O, Cauli A, Lubrano E, Krueger GG, van der Heijde D, Veale DJ, Kavanaugh A, Nash P, Ritchlin C, Taylor W, Strand V. Outcome measures in psoriatic arthritis. The Journal of Rheumatology. 34: 1159-66. PMID 17477479 |
0.333 |
|
| 2007 |
Prasad R, Ibanez D, Gladman D, Urowitz MB. The role of non-corticosteroid related factors in osteonecrosis (ON) in systemic lupus erythematosus: A nested case-control study of inception patients Lupus. 16: 157-162. PMID 17432099 DOI: 10.1177/0961203306075771 |
0.376 |
|
| 2007 |
Chandran V, Bhella S, Schentag C, Gladman DD. Functional assessment of chronic illness therapy-fatigue scale is valid in patients with psoriatic arthritis. Annals of the Rheumatic Diseases. 66: 936-9. PMID 17324972 DOI: 10.1136/Ard.2006.065763 |
0.482 |
|
| 2007 |
Hanly JG, Urowitz MB, Sanchez-Guerrero J, Bae SC, Gordon C, Wallace DJ, Isenberg D, Alarcón GS, Clarke A, Bernatsky S, Merrill JT, Petri M, Dooley MA, Gladman D, Fortin PR, et al. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis and Rheumatism. 56: 265-73. PMID 17195230 DOI: 10.1002/Art.22305 |
0.331 |
|
| 2007 |
Pellett FJ, Chandran V, Rahman P, Gladman DD. 92-P: KIR haplotypes in psoriatic arthritis families Human Immunology. 68: S61. DOI: 10.1016/J.Humimm.2007.08.115 |
0.404 |
|
| 2007 |
Pellett FJ, Chandran V, Martin MP, Carrington M, Gladman DD. 84-P: Unusual KIR haplotypes in patients with psoriatic arthritis and their family members Human Immunology. 68: S57. DOI: 10.1016/J.Humimm.2007.08.107 |
0.449 |
|
| 2006 |
Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: Development of new criteria from a large international study Arthritis & Rheumatism. 54: 2665-2673. PMID 16871531 DOI: 10.1002/Art.21972 |
0.358 |
|
| 2006 |
Prasad R, Ibañez D, Gladman D, Urowitz M. Anti-dsDNA and anti-Sm antibodies do not predict damage in systemic lupus erythematosus Lupus. 15: 285-291. PMID 16761503 DOI: 10.1191/0961203306Lu2302Oa |
0.324 |
|
| 2006 |
Kavanaugh A, Antoni CE, Gladman D, Wassenberg S, Zhou B, Beutler A, Keenan G, Burmester G, Furst DE, Weisman MH, Kalden JR, Smolen J, van der Heijde D. The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year. Annals of the Rheumatic Diseases. 65: 1038-43. PMID 16439444 DOI: 10.1136/Ard.2005.045658 |
0.423 |
|
| 2006 |
Kavanaugh A, Antoni C, Krueger GG, Yan S, Bala M, Dooley LT, Beutler A, Guzzo C, Gladman D. Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis. Annals of the Rheumatic Diseases. 65: 471-7. PMID 16096330 DOI: 10.1136/Ard.2005.040196 |
0.305 |
|
| 2005 |
Sarabi ZS, Chang E, Bobba R, Ibanez D, Gladman D, Urowitz M, Fortin PR. Incidence rates of arterial and venous thrombosis after diagnosis of systemic lupus erythematosus. Arthritis Care and Research. 53: 609-612. PMID 16082635 DOI: 10.1002/Art.21314 |
0.324 |
|
| 2005 |
Bernatsky S, Boivin JF, Joseph L, Rajan R, Zoma A, Manzi S, Ginzler E, Urowitz M, Gladman D, Fortin PR, Petri M, Edworthy S, Barr S, Gordon C, Bae SC, et al. An international cohort study of cancer in systemic lupus erythematosus. Arthritis and Rheumatism. 52: 1481-90. PMID 15880596 DOI: 10.1002/Art.21029 |
0.321 |
|
| 2005 |
Antoni CE, Kavanaugh A, Kirkham B, Tutuncu Z, Burmester GR, Schneider U, Furst DE, Molitor J, Keystone E, Gladman D, Manger B, Wassenberg S, Weier R, Wallace DJ, Weisman MH, et al. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT). Arthritis and Rheumatism. 52: 1227-36. PMID 15818699 DOI: 10.1002/Art.20967 |
0.422 |
|
| 2005 |
Butt C, Sun S, Greenwood C, Gladman D, Rahman P. Lack of association of SLC22A4, SLC22A5, SLC9A3R1 and RUNX1 variants in psoriatic arthritis. Rheumatology (Oxford, England). 44: 820-1. PMID 15769785 DOI: 10.1093/Rheumatology/Keh606 |
0.348 |
|
| 2005 |
Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Annals of the Rheumatic Diseases. ii14-7. PMID 15708927 DOI: 10.1136/ard.2004.032482 |
0.354 |
|
| 2005 |
Brockbank JE, Stein M, Schentag CT, Gladman DD. Dactylitis in psoriatic arthritis: a marker for disease severity? Annals of the Rheumatic Diseases. 64: 188-90. PMID 15271771 DOI: 10.1136/ard.2003.018184 |
0.371 |
|
| 2005 |
Gladman DD. Psoriatic arthrits Psoriasis and Psoriatic Arthritis: An Integrated Approach. 57-65. DOI: 10.1007/3-540-27190-2_7 |
0.307 |
|
| 2004 |
Liang MH, Fortin P, Schneider M, Abrahamowicz M, Alarcón GS, Bombardieri S, Balow J, Benito-Garcia E, Bischoff-Ferrari H, Buyon J, Chehab G, Costenbader K, Crofford L, Pablo PD, Esdaile JM, ... ... Gladman D, et al. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: Measures of overall disease activity Arthritis & Rheumatism. 50: 3418-3426. PMID 15529383 DOI: 10.1002/Art.20628 |
0.322 |
|
| 2004 |
Nelson GW, Martin MP, Gladman D, Wade J, Trowsdale J, Carrington M. Cutting Edge: Heterozygote Advantage in Autoimmune Disease: Hierarchy of Protection/Susceptibility Conferred by HLA and Killer Ig-Like Receptor Combinations in Psoriatic Arthritis Journal of Immunology. 173: 4273-4276. PMID 15383555 DOI: 10.4049/Jimmunol.173.7.4273 |
0.326 |
|
| 2004 |
Kaltwasser JP, Nash P, Gladman D, Rosen CF, Behrens F, Jones P, Wollenhaupt J, Falk FG, Mease P. Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial. Arthritis and Rheumatism. 50: 1939-50. PMID 15188371 DOI: 10.1002/Art.20253 |
0.321 |
|
| 2004 |
Prasad R, Gladman D. Current and investigational treatment of psoriatic arthritis Expert Opinion On Investigational Drugs. 13: 139-150. PMID 14996648 DOI: 10.1517/13543784.13.2.139 |
0.396 |
|
| 2004 |
Feletar M, Brockbank JE, Schentag CT, Lapp V, Gladman DD. Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients. Annals of the Rheumatic Diseases. 63: 156-61. PMID 14722204 DOI: 10.1136/ard.2003.006775 |
0.319 |
|
| 2002 |
Brockbank J, Gladman D. Diagnosis and management of psoriatic arthritis. Drugs. 62: 2447-57. PMID 12421102 DOI: 10.2165/00003495-200262170-00004 |
0.439 |
|
| 2002 |
Gu J, Märker‐Hermann E, Baeten D, Tsai WC, Gladman D, Xiong M, Deister H, Kuipers JG, Huang F, Song YW, Maksymowych W, Kalsi J, Bannai M, Seta N, Rihl M, et al. A 588‐gene microarray analysis of the peripheral blood mononuclear cells of spondyloarthropathy patients Rheumatology. 41: 759-766. PMID 12096225 DOI: 10.1093/Rheumatology/41.7.759 |
0.332 |
|
| 2001 |
Gladman DD, Farewell VT, Rahman P, Schentag CT, Pellett F, Ng CM, Wade JA. HLA-DRB1*04 alleles in psoriatic arthritis: comparison with rheumatoid arthritis and healthy controls. Human Immunology. 62: 1239-44. PMID 11704286 DOI: 10.1016/S0198-8859(01)00337-8 |
0.307 |
|
| 2000 |
Urowitz M, Gladman D, Bruce I. Atherosclerosis and systemic lupus erythematosus Current Rheumatology Reports. 2: 19-23. PMID 11123035 DOI: 10.1007/S11926-996-0064-9 |
0.352 |
|
| 2000 |
Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P. Endpoints: consensus recommendations from OMERACT IV. Outcome Measures in Rheumatology. Lupus. 9: 322-7. PMID 10878722 DOI: 10.1191/096120300678828424 |
0.329 |
|
| 1999 |
Dobkin PL, Da Costa D, Dritsa M, Fortin PR, Senécal JL, Goulet JR, Choquette D, Rich E, Beaulieu A, Cividino A, Edworthy S, Barr S, Ensworth S, Esdaile JM, Gladman D, et al. Quality of life in systemic lupus erythematosus patients during more and less active disease states: differential contributors to mental and physical health. Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association. 12: 401-10. PMID 11081011 DOI: 10.1002/1529-0131(199912)12:6<401::Aid-Art8>3.0.Co;2-F |
0.319 |
|
| 1998 |
Bruce IN, Gladman DD. Psoriatic arthritis: Recognition and management Biodrugs. 9: 271-278. DOI: 10.2165/00063030-199809040-00002 |
0.336 |
|
| 1996 |
Gladman DD, Urowitz MB, Ong A, Gough J, MacKinnon A. A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE) Lupus. 5: 190-195. PMID 8803889 DOI: 10.1177/096120339600500305 |
0.348 |
|
| 1996 |
Abu-Shakra M, Urowitz MB, Gladman DD, Ritchie S. The significance of anticardiolipin antibodies in patients with lupus nephritis Lupus. 5: 70-73. PMID 8646230 DOI: 10.1177/096120339600500113 |
0.345 |
|
| 1995 |
Goupille P, Valat JP, Gladman DD. Is methotrexate really effective in patients with psoriatic arthritis? [1] Journal of Rheumatology. 22: 2369-2370. PMID 8965271 |
0.316 |
|
| 1995 |
Gladman DD, Farewell VT, Nadeau C. Clinical indicators of progression in psoriatic arthritis: Multivariate relative risk model Journal of Rheumatology. 22: 675-679. PMID 7791162 |
0.304 |
|
| 1994 |
Gladman DD. Natural history of psoriatic arthritis Bailliere's Clinical Rheumatology. 8: 379-394. PMID 8076393 DOI: 10.1016/S0950-3579(94)80024-3 |
0.346 |
|
| 1994 |
Pauzner R, Urowitz M, Gladman D, Gough J. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus Journal of Rheumatology. 21: 1670-1673. PMID 7799347 |
0.317 |
|
| 1992 |
Singal DP, Green D, Reid B, Gladman DD, Buchanan WW. HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA. Annals of the Rheumatic Diseases. 51: 23-8. PMID 1371662 DOI: 10.1136/ard.51.1.23 |
0.336 |
|
| 1991 |
Gladman DD. Psoriatic arthritis - review of current concepts Israel Journal of Medical Sciences. 27: 228-233. PMID 2010280 |
0.314 |
|
| 1991 |
McCusker CT, Reid B, Green D, Gladman DD, Buchanan WW, Singal DP. HLA-D region antigens in patients with rheumatoid arthritis. Arthritis and Rheumatism. 34: 192-7. PMID 1994917 DOI: 10.1002/art.1780340210 |
0.321 |
|
| 1991 |
Gladman D. Gastrointestinal-related arthritis and psoriatic arthritis Current Opinion in Rheumatology. 3: 575-580. PMID 1911052 DOI: 10.1097/00002281-199108000-00003 |
0.456 |
|
| 1990 |
Hamilton ML, Gladman DD, Shore A, Laxer RM, Silverman ED. Juvenile psoriatic arthritis and HLA antigens. Annals of the Rheumatic Diseases. 49: 694-7. PMID 2241285 DOI: 10.1136/ard.49.9.694 |
0.339 |
|
| 1989 |
Buskila D, Gladman D. Atlantoaxial subluxation in a patient with psoriatic arthritis. Arthritis and Rheumatism. 32: 1338-9. PMID 2803333 DOI: 10.1002/Anr.1780321026 |
0.437 |
|
| 1981 |
Gladman DD, Keystone EC, Russell ML, Schachter RK. Impaired antigen-specific suppressor cell activity in psoriasis and psoriatic arthritis. The Journal of Investigative Dermatology. 77: 406-9. PMID 6457070 DOI: 10.1111/1523-1747.ep12494600 |
0.322 |
|
| Show low-probability matches. |